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Abstract 
Background: Neuroendocrine tumor (NET) is a chronic irreversible disease after 
metastases occur which has to be managed rather than cured. Getting an irreversible, 
slow growing cancer disease may be perceived as a health threat and cause stress. A 
balance between evaluation of individual disability and need for palliative treatment 
with the risk of adverse reactions may be a challenge in managing the disease. 
Interventions enabling patients to cope with stress and improve health related quality 
of life (HRQoL) may be a complementary treatment option. Personal resources such as 
social support and general self-efficacy have demonstrated to be associated with better 
HRQoL.  An intervention based on the principles of self-efficacy  to cope with stress 
and improve health outcomes in patients with NET is necessary and timely. However, 
the literature is sparse on issues of stress, general self-efficacy, social support and 
HRQoL in patients with NET.  
Aim: The objective of this thesis aims to 1) expand knowledge of  HRQoL in patients 
with NET; 2) evaluate the association between stress, general self-efficacy, social 
support and HRQoL  and 3) evaluate the importance of a patient education 
intervention based on the principles of self-efficacy. 
Methods: A cross sectional descriptive, survey design and an explorative, longitudinal 
design of three points in time were used. Recruitment of two different samples was 
collected in order to perform the studies.  In June 2007, data were collected at all NET 
centers nationwide for the cross sectional study and 196 patients returned the 
questionnaires. From September 2005 to December 2007, 37 patients from three of 
five NET centers completed the intervention data were collected for the exploratory, 
study. The questionnaires covered socio-demographic and self-reported HRQoL (SF-
36), stress (Impact of Event Scale), social support (Interpersonal Social Evaluation 
List) and general self-efficacy (General Self-efficacy). 
Results:  Chi-square statistics and Analysis of variance demonstrated that lower age, 
part-time or full-time employment, higher education and higher income levels were 
associated  better HRQoL. Bonferroni correction was used to adjust the level of 
significance. T-tests demonstrated that patients with NET had poorer HRQoL than the 
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general Norwegian population on all subscales of the SF-36 except for bodily pain. 
The largest difference demonstrated by effect sizes was general health, role limitations 
physical and vitality (Paper I). Multiple linear regressions demonstrated that having 
symptoms and co-morbid conditions predicted poorer HRQoL. In addition, higher 
stress was significantly associated with poorer mental and physical HRQoL and  
higher levels of social support and general self-efficacy were significantly associated 
with better mental HRQoL. Furthermore, higher levels of general self-efficacy were 
significantly associated with better physical HRQoL. Finally, social support and 
general self-efficacy partly mediated the relationship between stress-and mental 
HRQoL (Paper II). Mixed effect models showed that stress, general self-efficacy and 
physical HRQoL changed significantly following a 6- month patient educational 
intervention. Symptoms and co-morbidity were inversely associated with physical 
HRQoL(Paper III). 
Conclusion: Patients with NET demonstrated poorer HRQoL than the general 
Norwegian population on all subscales of SF-36, except bodily pain. Stress related 
negatively to poorer HRQoL and those with more social support and higher levels of 
general self-efficacy had better HRQoL than those with less social support and lower 
levels of general self-efficacy. In addition, social support and general self-efficacy had 
a partly mediating relationship with the stress-HRQoL association. The exploratory 
study demonstrated that stress was reduced and general self-efficacy and physical 
HRQoL were improved following the intervention. The intervention needs to be 
replicated in a RTC with appropriate sampling.  
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1. Introduction 
Neuroendocrine tumors (NET) or carcinoids are relatively slow growing and rare types of 
cancer. The incidence of NET is (5.25/100 000) and the prevalence is 35/100000 [1;2]. The 
cause of NET is unknown. NET most commonly arise from the gastrointestinal (GI) tract and 
tend to metastasize [3]. However, improved treatment strategies have contributed to better 
symptom control and possibly prolonged survival as patients may live many years with the 
disease [3;4]. The therapeutic challenge requires a balance between evaluation of individual 
disability and need for palliative treatment with the risk of adverse reactions.  Diarrhea, fatigue, 
pain, flushing, and dyspnea commonly put restrictions on daily life, in the form of reduced 
physical and social activity [5;6]. Consequently, disability may lead to reduced quality of life [7] 
[5;6;8-13]. Quality of life may be an important outcome when cure is not possible [14] because 
standard treatment may result in symptoms and adverse effects from all types of tumors. Prior 
research has focused on NET screening and detection practices, symptom control by medication 
[15-20] and survival rates [21-24].  
Getting a cancer diagnosis and experiencing symptoms and adverse effects may be 
perceived as a health threat and cause stress. Several authors have addressed stress issues 
negatively associated with health related quality of life (HRQoL) in cancer populations [8-
11;25]. However, there are several studies that have suggested that personal resources are 
positvely related to on HRQoL. Studies have shown a significant positve relationship between 
social support and HRQoL in men treated for prostate cancer [26] patients with breast cancer 
[27], spouses of men with prostate cancer [28] individuals at risk of hereditary cancer [8], and  
patients with long term survival following cardiac transplant [29]. General self-efficacy has also 
been reported as a personal resources; research demonstrated that individuals at risk for 
hereditary cancer reporting higher levels of general self-efficacy demonstrated better mental 
HRQoL [8]. In addition, research has shown that social support and self-efficacy may act as a 
mediator in the relationship of stressful life events on HRQoL. Consequencly the impact of 
stressful life events on HRQoL may be reduced by social support and self-efficacy [30-33]. 
Thus, interventions enabling patients to cope with stress and improve HRQoL   might be 
a complimentary treatment option. Core components of such interventions could be based on the 
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principles of self-efficacy in order to motivate the patients to take part in their self-development, 
adaptation and acquisition of new skills and competences. Different types of patient education 
interventions (e.g knowledge, patient and family education, provision of emotional and 
psychosocial support, self-efficacy, coping skills, and relaxation training) have been shown to be 
effective in reducing stress and improve HRQoL across settings and diseases [34-37].  In 
particular, patient education interventions based on the principles of self-efficacy have shown to 
enhance self-efficacy [38-41], and reduce stress [25;40;42], therefore enhancing HRQoL [43]. 
Improved HRQoL may yield beneficial effects by improving coping processes [34-36;44;45]. 
Consequently, the belief in patients’ own self-efficacy may affect their success in coping with 
their disease. On this basis, an intervention based on the principles of self-efficacy to improve 
health outcomes in patients with NET is necessary and timely.  
The literature is sparse on issues of stress, self-efficacy, social support and HRQoL in 
patients with NET. For example, some studies have reported on reduced HRQoL [46-48], but no 
studies have looked into psychosocial aspects of HRQoLnor different types of psychosocial 
interventions in patients with NET. The goal of health care is to prevent illness or deterioration 
and promote health. Health promotion means actively supporting the physical, social and mental 
well-being of the individual [49] (p. 95-98). In order to do so, the present thesis study aims to 
evaluate stress, social support and general self-efficacy in association with HRQoL in patients 
with NET. 
2. Aims of the thesis 
The objective of this thesis was to expand knowledge of HRQoL in patients with NET, evaluate 
the association between stress, general self-efficacy, social support and HRQoL,  and evaluate 
the importance of a patient education intervention based on the principles of self-efficacy. 
The main objectives of the papers comprising the thesis were to:  
x Describe HRQoL in a nationwide sample of patients with NET compared with a general 
Norwegian population (Paper I). 
x Evaluate associations between stress, general self-efficacy, social support and HRQoL  
(Paper II).   
x Evaluate changes in stress, general self-efficacy and HRQoL among patients with NET 
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following a patient education intervention (Paper III). 
3. Background; the clinical case of neuroendocrine tumors  
3.1 Definition and classification, epidemiology and etiology  
Neuroendocrine (NE) cells exist in most of the solid organs of the body and develop mainly 
from the nervous system. The two main functions of the NE cells are synthesizing peptide 
hormones and amino acids, which are saved within secretion granula and directly secreted into 
the circulatory system (endocrine function) or to the intercellular space (paracrin function). NE 
secretion granula are specific to the NE cells. The physiological functions of NET are 
production of insulin, glucagon, somatostatin and gastrin. NE cells are represented in both the 
central and peripheral nervous system. First and foremost NE cells are present in the mucous 
membranes of the body and the skin [50]. Gastro-entero-pancreatic neuroendocrine tumors 
(GEP-NETs) are rare tumors of the gastrointestinal tract arising from the cells of the NE system 
[50]. In 1907, Oberndorfer first used the term ‘‘karzinoide’’, a carcinoma-like neoplasm, to 
describe tumors in the intestinal tract, which appeared to have a more benign course than 
adenocarcinomas.  
The average age at time of diagnosis is 55 years although the disease has been seen in 
people in their twenties [51]. The most general GI-carcinoids are gastric carcinoids, small 
intestinal carcinoids, appendix carcinoids, colonic and rectum carcinoids. Carcinoid tumors are 
characterized by the production of high amounts of hormonally active substances including 
serotonin, bradykinins, and tachykinins. Chromogranin A (CgA) is a secretory protein that is 
presented in all NE cells and is a tumor marker. In all the tumor subgroups high levels of CgA, 
PP and human chlorionic gonadotrophin (HCG) α and ß may be found. They are responsible for 
the carcinoid syndrome that is manifested by flushing, diarrhea, carcinoid heart disease and, less 
commonly, wheezing [51].  
The pathology of NET is assessed and classified by specialized histochemical methods 
and electronical microscopy. Most gastric endocrine tumors arise in the mucosa and hyperplasia 
of endocrine cells and formation of extra-epithelial clusters that produce histamine may occur. 
Also gastric gastrin producing tumors have been described associated with Zollinger Ellison 
Syndrome (ZES) or Gastrinoma Syndrome [50]. The most common tumor of the duodenum is 
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the gastrin producing tumor of the small intestine; argentaffin (EC-cell, serotonin producing).  
Glucagon-glicentin is the predominant tumor component of the large bowel and is less 
commonly malignant [4;50]. Carcinoid tumors are often multiple. Genetic predisposition has 
been demonstrated for duodenal gastrinoma in multiple endocrine neoplasia (MEN1)[1].  
 The World Health Organisation (WHO) defines the entire group of tumors as neuroendocrine 
neoplasms and divides the tumors into NET G1, NET G2 and poorly differentiated 
neuroendocrine carcinoma; NEC G3. The European Neuroendocrine Tumor Society has 
proposed a tumor – node – metastasis staging and grading system for various types of GEP-NET 
based on levels of Ki-67 [2].  KI-67 is a protein associated with cellular proliferation and is a 
cellular marker. Levels of Ki-67 reflect the differentiation of the tumor cells. Aggressiveness is 
related with tumors with liver an lymph node metastases and high proliferation by Ki-67 and 
levels of hydroxyindoleacetic (U-5-HIAA), neuropeptide K and CgA in plasma [23;50].  
In summary, NET is a rare, slow growing disease that tends to metastasize. The production of 
neuroendocrine tumor hormones give rise to symptoms that vary widely and surgical treatment 
may be the only cure if performed prior to metastases.  
3.2  Survival and prognosis 
Survival depends on a number of factors such as original tumor site and aggressiveness [1]. 
Length of survival is directly related to both the extent of the disease and the time of diagnosis 
and the degree of differentiation of the tumor [1]. Nevertheless, data show that the 5-year 
survival of all patients with NET regardless of primary site and degree of spread did not change 
between 1973 and 2002 and remained at 60 – 65 % [1]. Current research predicts the 5- and 10- 
year survival rates in a Norwegian sample to be 78% and 53 % respectively [51].  
Reports in the literature vary regarding primary tumor size and the presence of distant 
metastases at diagnosis. The size of carcinoid tumor may be used as a prognostic indicator; 
larger than 2 cm in diameter is considered malignant and metastasis is likely to have occurred 
[1;2;50]. A poorer prognosis in NETs and distant metastases were associated with elevated 
levels of U-5HIAA and CgA ratio ≥6.2, and Ki-67 values ≥ 5%, age ≥64, male gender and the 
presence of carcinoid heart disease [51]. The overall 5-year survival for patients with no 
metastases at diagnosis was 94%, for those with regional disease 85%, for those with liver 
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metastases 63%, and for patients with distant metastases without liver involvement, 75%. 
Survival was significantly decreased in patients with distant metastases compared to the group 
with local or regional disease. Five-year survival for primary tumors ≤1 cm was 85%, >1-2 cm 
77%, and >2 cm 78% [51]. A significant difference in survival based on primary tumor size 
among the patients with SI-NET was not found in the Norwegian sample [51]. The results 
emphasize an important clinical feature of NETs where even small primary tumors may be 
associated with metastases and decreased survival [51]. Distant liver metastases at time of 
diagnosis, elevated CgA-levels and advanced age were significant predictors of survival [51]. 
NET represents a complex group of tumors with remarkable variation in the course of the 
disease. The level of specializing of the team in managing the NETs vary on survival rates [1]. 
Thus, multidisciplinary teams at referral centers should give guidance on the definitive 
management of patients with all varieties of NET.  
3.3  Course of disease 
Disease refers to a condition that is viewed from a patho-physiologic model, such as an 
alteration in structure and function [52] (p 4). NET is such an alteration. 
Illness is the human experience of symptoms and suffering, and refers to how the disease is 
perceived, lived with, and responded to by individuals and their families [52] (p 4). 
Understanding the illness experience is essential in providing holistic care [52] (p 4).  
Chronic disease is considered an irreversible presence, accumulation, or latency of disease status 
or impairments that involve the total human environment for supportive care and self-care, 
maintenance of function, and prevention of further disability [52] (p 6). NET may be regarded 
chronically as the patients may live for a long time and the symptoms are relieved with adequate 
medical treatment [51;53]. There is no single onset pattern of chronicity, hence, a chronic 
disease can appear suddenly or through insidious process, have episodic flare-up or 
exacerbations or remain in remission with absence. Consequently, balancing treatment regimens 
while focusing on quality of life consists of maintaining wellness or keeping symptoms in 
remission [52] (p 5). 
The majority of patients with NET are facing progression disease at the time of diagnosis due to 
lack of initial symptoms. In earlier stages, radical surgery may be possible. Resection of the 
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primary lesion should always be considered in metastatic disease, due to risk of local 
complications over time. Because of the relatively slow progression of the disease, the disease 
trajectory resembles that of the chronically ill patient [54]. The illness trajectory consists of 
regressive steps in the course of the illness, with stable and downward phases [1;4;55]. A 
common challenge in NETs is often the variable period of non-specific symptoms before 
diagnosis, with a range of two weeks to 21 years of symptoms before diagnosis [1;51]. The most 
common presenting symptoms are diarrhea, weight loss, fatigue, flushing, nutrition intolerance, 
restlessness, fluctuating mood and other non specific symptoms and pain [4;50;51;56]. The 
symptoms may affect many dimensions of the patients life, and does not only reduce the 
patient’s activity and physical capacity, but may also cause discomfort, anxiety about the 
progress of the disease, and depression. If right heart valves are involved, right heart failure may 
occur and cause breathlessness [57;58].  
3.4  Standards of clinical management 
For the purpose of this thesis, clinical management includes medical treatment of the disease 
trajectory and care for symptoms and prevention of deterioration of the illness. The European 
Neuroendocrine Tumor Society (ENETS) consensus conferences have produced guidelines on 
the pharmacological management and medical control of NET [59]. No guidelines exist for 
patients with NET or for patient education. However, Norwegian legislation regulates the 
patients´ rights for information and education [60]. Additionally, evidence should be the basis 
for information and patient education in coping with the disease [61]. Pharmacological 
management consist of biological agents such as somatostatin analogues, interferon-α [1;1;2]. 
Embolization, debulking or radio-isotope are options for treatment of liver metastases, and valve 
replacement by open heart surgery if the valves are affected [1;1;2]. Optimal management can 
stabilize and delay disease development [62]. Regular, annual medical visits for 10-15 years  is 
preferred, initially at  six months intervals and some times more frequently, because relapse may 
occur [1;2;62]. When the disease appears to be stable, the intervals between visits may be less 
frequent, the “follow up” visits consist of clinical blood status, CgA in serum, x-ray, CT 
scanning and MR.  
Patients diagnosed with and treated for NET may have a risk of side effects of treatment and 
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progression of the disease [1;2]. Psychosocial consequences due to the uncertainty of the 
changes in disease trajectory may lead be stress reactions. In some cases, the symptoms such as 
diarrhea and fatigue may limit social activities and thus, social isolation may occur [56]. Side 
effects of medical treatment may influence daily activities mentally, physically and socially, and 
consequently, impact HRQoL. The aim of the treatment is to keep the patient disease and 
symptom-free for as long as possible and to maintain a good quality of life. In order to achieve 
optimum health and HRQoL and to prevent subsequent events and improve secondary 
prevention efforts, patient information and education should be emphasized [63]. Patient 
education may be understood as “any set of planned, educational activities designed to improve 
patients’ health behaviors, health status or both” [36].  The purpose of patient education is “to 
maintain health and, in some cases, to slow deterioration. These purposes are met through 
changes in behaviors, mental attitudes, or both” [64]. Patient education and secondary 
prevention strategies in daily practice are still inadequate in Norway and there exists no standard 
guidelines, providing patients with health information and education. In addition, providing 
patients with information and education may enable them to take an active part and be 
responsible for their own health and social functioning [61;65].  Through a patient education 
program the patients may better cope with their disease, prevent complications, problem solve, 
make appropriate decisions, increase confidence, and place patients and health professionals in a 
partnership relationship [61;64;65].  
A patient educational program that is relevant and tailored to the patients needs and interests is 
desirable. Furthermore, a program that is action based specifically to help patients make the 
necessary changes in their lives; may provide patients the opportunity to self-monitoring their 
own progress and reward and encourage patients when they succeed. Finally, the patients can 
determine their progress in dialog with their health care personnel [66] (p 65 - 76)  
In order to improve the problem of lack of knowledge and information, and experience of stress 
due to the uncertainty of the disease trajectory, treatment and symptoms, it is likely that patients 
receive follow- up service in the period after diagnosis. However, the period should start when 
the patient feel comfortable and be in the phase of new orientation soon after diagnosis [67]. 
Results from studies in chronic disease populations revealed that program content, timing, 
providers, approaches, and settings have been provided as a single intervention, in combination 
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with, or  as a supplement to standardized care. The interventions have included the following 
approaches; consultations at hospitals, educational sessions, group sessions, support groups and 
telephone follow up. The timing has varied from two weeks to 12 months [34-36]. 
To consider whether educational goals have been achieved at the individual level the following 
issues should be assessed; are psychosocial problems present and, has the patients´ HRQoL 
improved? Research indicated that group sessions were an intervention that showed promise, 
and was used to plan follow-up interventions for this study [37]. Timing for the intervention was 
based on recommendations [68] and followed a guide especially performed for patients with 
NET. However, improving the patients’ knowledge, sessions with teaching and telephone 
follow- ups were also warranted.  
4. The main concepts 
4.1 Health related quality of life 
Quality of life has been an important objective of research in recent decades. This is explained 
by the increasing focus on the importance of patient reported outcomes in determining the 
efficacy and impact of care across settings and disease contexts [69;70]. Quality of life is an 
important parameter for evaluating the quality and outcome of health [71;72]. 
Quality of life represents the range of human experience, and usually refers to overall well-being 
or life satisfaction [71;73;74].  The concept of quality of life is separate from health, but is 
related to it [43;72] and refers to a broader construct encompassing HRQoL. Thus, quality of life 
seems to be an umbrella term that includes various concepts such as functional status perception, 
life conditions, behavior, lifestyle and symptoms. Spilker (1996) has illustrated quality of life as 
a pyramid of three different levels; i) overall satisfaction with life; ii) the generic level such as 
the individual’s satisfaction with different life domains (physical, psychological, economic, 
spiritual and social); and iii) disease specific symptoms or disability [75].  Quality of life is often 
used as a general construct to describe subjective and psychosocial variables [76]. WHO has 
defined quality of life as: 
“ Individuals perception of their position in life in the context of the culture and value-
systems in which they live and in relation to their goals, expectations, standards and 
concerns. It is a broad ranging concept affected in a complex way by the individual´s 
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physical health, psychological state, level of independence, social relationships, personal 
beliefs, and their relationship to salient features of their environment” (p 1405). 
The definition of quality of life reflects an individual subjective appraisal of health status and 
well being that is influenced in complex ways by a broad array of factors. Health related quality 
of life has been strongly influenced by the definition from the HWO in 1948; “Health is the state 
of complete physical, mental and social well-being and not merely the absence of disease and 
infirmity” [77]. HRQoL reflects current levels of health status and well-being and is not age, 
disease or treatment specific [78].  In addition, the parts of the construct affect each other and 
their overall summation. The dynamic nature of HRQoL poses measurement challenges. 
HRQoL is composed of both positive and negative experiences and affects. Self-perceptions of 
life may change over time in response to life and health events, as well as experiences. 
Consciously or unconsciously, individuals may accommodate, adapt or adjust to deteriorating 
circumstances, either in relation to health or other factors. To feel as good as possible about 
oneself, one may do this. Thus, the experience of HRQoL may be understood as a dynamic 
process. In the present study HRQoL is used and defined as a subjective and multidimensional 
concept including physical functioning, social functioning, role functioning, pain, vitality, 
general health perceptions and mental health [79]. 
Based on the Wilson & Cleary model, Ferrans et al (2005) have suggested a modified theoretical 
model for a subjective perception of quality of life related to how satisfied an individual is with 
of her life as a whole (see Figure 1) (83). The purpose of the model is to distinguish between 
conceptual measures of quality of life and to suggest their dominant causal associations. Polit & 
Beck (2008) claim that a conceptual model guides the relationship among the concepts as well 
as a basis for generation of research hypotheses [80]. In this thesis, Ferrans’ model (Figure 1) is 
used to understand the difference between constructs relevant for the theoretical and 
methodological framework and how clinical variables are linked with HRQoL. The model is not 
grounded in a specific quality of life definition and consists of a combination of the biological 
and sociological approach. It is likely that patients with NET experience biological, 
physiological and psychosocial changes when diagnosed. These changes justify the use of a 
conceptual model that combines these paradigms in HRQoL research in patients with NET. 
Wilson and Cleary´s model has been used frequently in nursing research [81;82].  
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According to, Ferrans et al (2005), overall quality of life and general health perceptions exist on 
a continuum of increasing ideal biological function on one end and more complex and integrated 
measures of health perception and overall quality of life on the other end. The first level includes 
biological-physiological variables and traditional clinical variables, as well as physiological 
examinations. The second level is the perception of an abnormal physical, emotional or 
cognitive state is considered to be an important determinant of functioning. The third level, 
functional status is the ability to perform particular defined tasks. The fourth level refers to 
subjective health that integrates all of the preceding concepts representing an integration of 
symptom status, functional status and the biological variables. The fifth level, quality of life, is 
considered as the rating of the perception of satisfaction with life as a whole.  Each of the levels 
in the model is influenced by individual and environmental characteristics  [83].  Although the 
arrows in the model are shown in only one main direction Wilson & Cleary point out that the 
relationships may be bi-directional [74]. Therefore, all the variables may serve as mediators to 
overall quality of or vice versa. In this thesis, we included the variables of medical diagnosis, 
stress, disease related symptoms, co-morbidity and, social support and general self-efficacy. 
This thesis is focused on the generic level of HRQoL as an outcome and is elaborated in paper I, 
II and III.  
In summary, the definition of HRQoL and the conceptual model developed by Wilson 
and Cleary and adapted by Ferrans consider HRQoL to be a subjective phenomenon as well as a 
multidimensional concept of core elements. The model can be used as a conceptual model 
linking concepts together with HRQoL. 
 
Figure 1. The Conceptual model for health related quality of life by Ferrans, C. E., Zerwic J. J., 
Wilbur J. E., and Larson, J. L., 2005. The model is used with the permission of Dr. Ferrans et al 
and Journal of Nursing Scholarship (Ferrans CE. et al, Model for health-related quality of life. 
2005, 37(4), 336-342. Copyright © Journal of Nursing Scholarship 2005).  
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4.2  Stress 
Receiving a cancer diagnosis represents a stressful experience [9-11;84]. Stress may be 
understood as the response to a threatening event [85] which is complex and  based on the 
perception of the individual’s experience and self-report [86;87]. In the present study stress is 
used and defined as intrusive thoughts and avoidance related to a specific event in line with 
Horowitz` understanding of these concepts: 
 “Intrusion is characterized by unbidden thoughts and images, troubled dreams, strong 
pangs or waves of feelings, and repetitive behavior. Avoidance responses included 
ideational constriction, denial of the meanings and consequences of the event, blunted 
sensation, behavioral inhibition or counter- phobic activity, and awareness of emotional 
numbness” [88] (p. 210).  
Intrusive and repetitious symptoms are common after exposure of extreme stress, whereas 
avoidance symptoms are less common. Living with a cancer diagnosis involve the uncertainty 
about the disease trajectory and if or when the disease would cause the death. Consequently, 
according to Horowitz (1979) [88] living with NET may represent an overwhelming, stressful 
experience that may release responses such as intrusive thoughts and avoidance of the specific 
event that releases the intrusive thoughts. An overwhelming sense is often experienced with 
feelings of fear combined with matching physiological reactions such as sweat, increased heart 
rate and restlessness. Avoidance behaviors arise from attempts to block unpleasant feelings and 
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thoughts and usually follows the overwhelming effort of reducing the disturbing event [89]. 
Consequently, HRQoL may be influenced by stress responses. This study includes stress as a 
symptom, which potentially relates directly to health outcomes as well as influences HRQoL. 
This is specifically elaborated on in papers II and III.  
4.3  General self-efficacy 
Bandura based the social cognitive theory on the concept of self-efficacy elaborating on the 
understanding that humans are direct agents in shaping and responding to environmental 
conditions, and that human motivations and actions are regulated by forethoughts [90]. Self-
efficacy is the belief in one’s competence to take on difficult or novel tasks, and to cope with 
adversity arising from specific demanding situations [91] and makes a difference in how people 
feel, think and act [90]. This may reflect the persons’ ability to problem-solve in general. Thus, 
improving the patients’ self-efficacy may act as a basis for problem-solving strategies. Self-efficacy 
influences the choice of activities and motivational level, thus, beliefs of personal efficacy make 
an important contribution to the acquisition of the knowledge on which skills are founded. The 
person’s belief in his own ability to cope with different challenges and to exert some control 
over environmental events is the central mechanism [92]. In this study self- efficacy is defined 
as “beliefs in one’s capabilities to organize and execute the course action required producing 
given attainments” [90] (p 3). Furthermore, “the effect of self-efficacy influences the course of 
action chosen by the individual, how much effort they put into it and how long they will persist if 
they first fail, and how much stress and depression they experience in coping environmental 
demands and level of accomplishments they realize” [90] (p 3). Therefore, self-efficacy plays an 
important role, as well as knowledge and skills, in health promoting behaviors [32;33;90]. For 
example, in patients with NET self-efficacy may be reflected in the individual’s belief in their 
ability to manage symptoms and produce desired effects in a given activity, problem or 
unexpected challenge which, includes problem solving. The beliefs influence whether the patient 
is pessimistic or optimistic in performing different tasks. Self-efficacy may be reflected in the 
patients´ beliefs in their ability to deal with stressful situations and thus, their ability to solve 
problems related to the stress. Hence, perceived self-efficacy may be an important resource in 
performing different tasks and in determining activities or situations to perform or avoid. 
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Self-efficacy may depend on the initial sense of self-efficacy and beliefs in the positive outcome 
to the new challenge [90]. However, initial beliefs about competencies may increase as, the 
patient is able to cope and adjust their behavior [93-95]. Self-efficacy is influenced by the 
interaction of personality, social environment and behavior. The dynamic process of how 
personality, social environment and behavior influences a person´s personal agency may be 
viewed as the basis  for developing a person´s self-efficacy. Realization of personal agency 
requires self-observation of the outcomes that flow from actions. By repeatedly observing 
actions following environmental events, individuals learn that actions produce effects. Hence, 
internal and external feedback lead to individually self-evaluation and self-regulation toward a 
desired result. The self-regulation usually occurs through modification of behavior and 
perception of control. In this process the individual develops self-efficacy and provides the basis 
for behavior. Perceived self-efficacy is defined and measured independently of performance 
[90]. In order to complete an action, important predictors of motivation are a combination of 
perceived self-efficacy and outcomes expectation and knowledge as well as perceived control. 
Therefore, if people believe that their actions can make a difference, then they have much 
incentive to act. Contrastingly, low confidence in performing activities implies low self-efficacy 
and makes it less likely that an individual will act [90]. 
Efficacy beliefs are patterned differently in different individuals in levels, generality and 
strength. The beliefs are patterned in one level if they refer to a simple demand, and to another 
level if they refer to difficult demands of performing within a particular domain or function. The 
range of perceived capability for a given person is measured against levels of task demands that 
represent varying degrees of challenge or impediment to successful performance. When patients 
engage in a particular situation and experience unknown symptoms, self-efficacy can be 
improved by learning about NET related symptoms, for example. Hence, the extent of 
applicability of a generalized domain to a new situation is of importance. Patients with NET may 
feel successful when performing exercise unsupervised after a successful supervised exercise. 
Strength refers to the confidence people feel they have in accomplishing the particular task [90]. 
To perceive self-efficacy, four sources of skills are necessary: enactive mastery experience, 
vicarious experience, verbal persuasion and strengthening physical and affective state [90]. 
Mastery experience serve as an indicator of capability in that the individual’s experience of 
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success in being able to perform a desired action or engage in a particular cognition may act as 
an incentive for behavioral change. Mastery experience is the most influential source of efficacy 
information because it provides authentic evidence of whether one can master whatever it takes 
to succeed. A resilient sense of efficacy requires experience in overcoming obstacles through 
perseverant effort [90] (s. 80).  Vicarious experience influences efficacy appraisals through 
modeled attainment in that the sharing of experiences and learning from other patients or 
individuals who succeed in valued activities promote a sense of personal capacity. Verbal 
persuasion is trying to encourage other persons to believe in their own capacity to reach their 
goals. Strengthen physiological and affective state is strengthening the individual`s knowledge 
in human physical and mental reactions by internal and external influence. Hence, the 
individuals exercise control over functioning [90]. Based on the abovementioned, self-efficacy 
may be an important characteristic in how patients cope with NET. The four sources of skills to 
perceive self-efficacy might be seen as useful tools in problem solving strategies. 
Though Bandura indicates that self-efficacy is context specific and that assessment methods 
must be tailored to an event or research setting, some researchers prefer the concept of general 
self-efficacy [96]. The idea of the universal construct is that the concept of general self-efficacy 
may be of a general character. General self-efficacy refers to a global confidence in one’s coping 
ability across a wide range of demanding and novel or stressful situations. The levels and 
amount of exposure to challenges and demanding situations through the lifespan vary between 
individuals. It is likely that challenges and demanding situations of general character may 
influence a persons´ daily life. Consequently, the person´s ability to cope with situations in 
general may influence the person´s levels of stress and HRQoL. Thus, it is important to evaluate 
not only how the individual copes with disease, but also with general situations influencing the 
individual´s life. In this study, the concept of general self-efficacy will be used. General self-
efficacy is specifically elaborated on papers II and III. 
4.4 Social support 
Social support refers to a variety of phenomena that characterize an individual’s social 
environment. Social support is a multidimensional construct and refers to the degree to which 
individuals are socially embedded and have sense of belonging, obligation and intimacy, and 
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reflects the function and quality of social relationships. Social support may be resources 
provided by others, such as coping assistance, an exchange of social resources [97],  or more 
formalized support  such as health care services [98]. Thus, social support occurs through an 
interactive process that provide information, advice, and feedback [8;97]. Seeking social support 
seems to be one of the most successful coping strategies that lead to favorable health outcomes 
[97;98]. There are two types of social support; structural and functional [99]. Structural social 
support refers to the presence of social relationships. Functional support, or perceived support, 
refers to an individual’s perceptions of the resources available in the social network that are 
perceived as supportive. Social environment includes family, friends and healthcare providers 
who have influence over when and where health care is sought and whether treatment is adhered 
to. Many of the constructs of social environment may have implications for health [100]. Cohen 
(2004) assumes that social support protects a person against the pathologic effects of stressful 
situations, but is relatively unimportant for the person’s health and well-being in non-stressful 
situation [100].  Consequently, social support is activated when needed and  social connections 
benefit health by providing psychological and material resources that are needed in coping with 
stress. Cohen (2004) also claims that social support and personal characteristics such as general 
self-efficacy are least partly independent of one another, and there are few studies addressing the 
overlap [100]. 
The literature on social relationships and physical HRQoL is relatively small. In the current 
study, social support is defined in five ways; support for self-esteem or the extent to which 
people feel accepted; emotional closeness or the extent to which people feel emotional 
confidence and; tangible aid or the provision of materiel resources such as money or service; 
group belonging or spending time with others; and appraisal support or assistance defining and 
understanding difficult events [101]. The concept of social support is addressed in paper II.  
4.5 Patient education 
We hypothesized that patient education, informed by Bandura’s social cognitive theory, and 
strategies in enhancing self-efficacy [90] may improve HRQoL in patients with NET. Strategies 
for enhancing self-efficacy incorporate mastery experiences, vicarious experiences, social 
persuasion, and strengthening physical and psychological state [32;90].  
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Mastery experience may be integrated into a patient education intervention by writing individual 
goals. Mastery experience develops when people become convinced that they have what it takes 
to succeed; they persevere in the face of adversity, and rebound from setbacks. Mastery may 
result from experiencing hard times, in which the patient may emerge stronger and more able to 
perform tasks. However, appraisal of personal efficacy also depends on preconceptions of the 
individual’s capability, the amount of effort they expend, the perceived difficulty of the tasks, 
the amount of external aid they receive and under which circumstances they perform. Further, 
the temporal pattern of their successes and failures, and the way these experiences are 
cognitively organized and reconstructed in memory are important. One of the main mechanisms 
is internal motivation [90];  the patient must want to achieve change. Motivation is related to the 
patient´s will [90]. For example, the patient may want to achieve better physical conditioning but 
has fatigue and thinks that he/she is unable to perform physical activities. However, the patient 
may be willing to perform an action to achieve a reward. A relevant question from the nurse will 
be to ask the patient to suggest an alternative to resting. When the patient answers what he/she 
might do, the following response from the nurse might be; how are you going to do it and/or 
how often do you want to do it?  Every answer the patient gives, comes from him self, from the 
internal motivation of wanting or not wanting to do something. In addition, the suggestion from 
the patient is likely to be realistic and workable for him/her. The final question is to ask the 
patient how realistic the suggestions are on a scale of 0 -10. If the assessment is below 7, the 
nurse should ask the patient to reconsider and formulate a new plan that is achievable. It is 
important that the patient achieve their goal and experience success in order to be motivated to 
continue working toward their goals. If the patient assesses the achievability of their goal to be 7 
or more, then the plan is realistic and the nurse should support and recognize the patient´s 
performance.   Vicarious experience depends on processes governing the impact of modeling 
self-efficacy such as modes of modeling, performance similarity, attribute similarity, 
multiplicity and diversity, coping versus mastery and competence of modeling. The group 
sessions integrated shared positive experiences as a means of support and to role model for each 
other. Verbal persuasion includes giving feedback, which highlights the person’s capabilities 
and in turn may raise efficacy beliefs. The last strategy, physiological and affective state, is 
strengthened by managing NET specific symptoms and identifying malignant changes in 
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physical state due to NET disease. When patients learn to identify symptoms, they become more 
convinced of their ability to solve problems and discomfort such as diarrhea and fatigue and, 
stress.  Lorig’s (2001) research results demonstrate improved self-efficacy and improved health 
outcomes following a patient educational program [41;102-107]. Patient education is addressed 
in paper III. 
5. Prior research 
5.1 Health Related Quality of Life in patients with Neuroendocrine Tumors 
compared with the General Norwegian Population  
Age, co-morbidity, and lower annual income are independently related to lower levels of all 
HRQoL subscores among men with prostate cancer [108] contrary to patients with pancreatic 
neuroendocrine tumors (n = 44) were there were no relationship between age, gender, disease 
duration, marital status and disease duration and HRQoL [7]. Results from a study of mostly 
men (71%), mean age 59 years, diagnosed with non-small cell lung cancer, show that older 
people could not function as well as younger people [109]. In a comparative study a sample of   
long-term survivors of testicular cancer (n =1409), mean age 44 years, demonstrated more 
bodily pain, less vitality and poorer social functioning but better mental HRQoL than a sample 
of the general population [10]. The testicular cancer surveillance study also reports lower mental 
component scores, compared with the general norm population. The physical component score, 
however, did not differ from the general norm sample.  
Another prospective study reporting HRQoL in 141 Japanese patients with prostate cancer, 
shows that the mental health subscale was the only subscale that differed significantly from  
Japanese population norms [110]. Larsson (2010) demonstrates that a sample of women with 
breast cancer (n = 85) experiences significantly poorer HRQoL on all sub-scales except general 
health compared to a sample of the female general population. The results may be confounded 
by age since groups varied significantly by age (breast cancer patients ranged from 30-80 years 
vs. controls ranged from 55-64 years). The patients received adjuvant treatment such as 
chemotherapy, radiotherapy and hormones, separately or in combination, or no therapy [111]. 
Moreover, a cross sectional study of individuals at risk of hereditary cancer  (n = 121) 
demonstrates similar mental component scores and higher levels of physical component score 
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compared with a sample of the general population [8]. Age was negatively associated with 
physical component HRQoL while level of education was positively associated with physical 
component scores of HRQoL.  
 In a cohort study, Berglund et al [47] compared HRQoL among 29 Swedish patients with 
multiple endocrine neoplasia type 1 (MEN1), with matched population-based norm values. The 
age of the MEN1 sample ranged from 28 to 77 years, the distribution of gender was similar and 
the disease duration ranged from < 1 year to 30 years. The authors found that patients with 
MEN1 have significantly lower levels of general health and social functioning. In addition, a 
longitudinal study of 24 patients with NET scored 10 points or more below expected s for two 
function scales and symptom scales at baseline measured by a cancer specific quality of life 
questionnaire.  The results demonstrate significantly poorer physical and social function, global 
health, nausea/vomiting and diarrhea measured by European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC QOQ-C30) at 12 months following 
diagnosis, compared with Swedish population-based norm values [56]. In a longitudinal, 
prospective, and comparative study, another sample of 59 patients with NET demonstrate poorer 
cancer related HRQoL measured by EORTC QOQ-C30 on all subscales than the Swedish norm 
population at baseline as well as 12 months post diagnosis. The mean age was 60 years and 81 
% was on sick leave or old age pensioner. Seventy percent had developed metastases [112].  
Patients with pancreatic neuroendocrine tumors (n = 44) demonstrated significantly poorer MCS 
measured by SF-12 and General Health Quality-12 than the Italian general population [7]. A 
retrospective, comparative study of Beaumont et al (2012) shows that patients with NET (n = 
663) have statistically significant poorer HRQoL SF-36 than the general US population [13]. 
Effect sizes were large for physical functioning, role limitation-physical, general health and 
vitality indicating that these factors may have clinical importance for patients with NET.  
In summary, studies demonstrate that age, gender, co-morbidity and treatment are related to 
HRQoL. However, few studies have evaluated individual characteristics in association with 
HRQoL. Prior research of HRQoL in patients with cancer compared with general norm 
populations shows inconsistent results across settings and disease contexts. Generally, it appears 
that patients with cancer have a lower HRQoL compared to healthy populations. No studies have 
evaluated multivariate relationships between socio-demographic characteristics of the 
 
 
19 
 
individuals and HRQoL in patients with NET. In addition, no studies have compared the health 
related quality of life of the Norwegian NET population with a population- based norm. 
5.2  Associations between Stress, General Self-efficacy, Social Support and 
Health Related Quality of Life 
5.2.1  The relationship between stress and health related quality of life 
Researchers have been seeking to discover the influence of stress on health related quality of life 
for decades [27;86;113-116]. Several authors have addressed symptoms of stress that are 
negatively association with disease related HRQoL in patients with cancer [26;42;114;117-119]. 
A follow up prospective study by van deWiel et al (2008) demonstrates that intrusive thoughts 
and feelings were significantly negatively associated with the MOS-36 Short Form Health 
Survey subscores of mental health and general health as well as the mental and physical 
component scores in women following breast cancer surgery (n = 83) [11]. Furthermore, 
avoidance-subscore measured by the Impact of Event Score tool relates significantly with the 
bodily pain sub-scale. In Mykletun’s study (2005), stress is strongly negatively related to both 
physical and mental health in long term survivors (n = 1409) after treatment for testicular cancer 
[10]. In addition, results of a study of individuals at risk for hereditary cancer, attending genetic 
counseling, demonstrate significant negative associations between stress and mental health [8]. 
In a sample consisting of patients with breast cancer, stress does not predict negative mental 
health on the SF-36 [120].  
In summary, a preponderance of research demonstrates negative associations between stress as 
measured by intrusion and avoidance, and mental and physical HRQoL in patients with cancer. 
Although Larsson (2003) [121] show  a negative association between distress and cancer 
specific HRQoL in patients with NET,  no studies have  measured stress with the Impact of 
Event Scale modified to be NET specific. Identifying stress influenced by NET may be 
important information for health personnel when planning strategies in order to help the patients 
in the coping process. 
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5.2.2 The relationship between general self-efficacy and health related quality of 
life 
Self-efficacy has been a consistent predictor of quality of life in patients across chronic 
illness conditions [34-36;39;44;45;122-127]. Research has focused on associations between 
disease-related self-efficacy and disease-specific quality of life [104;126;128-130]. In addition, 
general self-efficacy may be associated with a broader spectrum of quality of life [131].  
However, there has been little emphasis on the associations between general self-efficacy and 
HRQoL in patients with cancer. Higher levels of general self-efficacy are related to better 
HRQoL in individuals attending counseling at risk for hereditary cancer [8] and  for patients 
with rheumatoid arthritis [132].  In addition, results from a cross sectional study demonstrate a 
direct positive relationship between general self-efficacy and physical functioning assessed by a 
MOS-20 questionnaire in 104 patients with HIV [125].  
In summary, general self-efficacy has been a positive predictor of  HRQoL. Although 
several authors have suggested that self-efficacy were associated with less stress [133-135], no 
studies have evaluated the association between general self-efficacy and HRQoL, nor the 
mediation role of general self-efficacy on the association between stress and HRQoL in patients 
with NET. Improved general self-efficacy may enable patients to better solve problems which 
may be useful in coping  with stressful situations. Thus, they may take part in their self-
development. Based on their beliefs in succeeding in coping with the disease, HRQoL may be 
enhanced,   
5.2.3  The association between social support and HRQoL 
Cohen [87] claimed that there is an association between social support and HRQoL in that, those 
with more social support have better HRQoL than those with lower social support. In addition, 
the benefit of social connections exists irrespectible of whether one is under stress [100]. This 
may be explained by the suggestion that individuals who participate in a social network are 
subject to social controls and peer pressures. Social controls and peer pressures may influence 
normative health behaviors related to exercise, diet, or smoking. Social interaction may result in 
feelings of responsibility for others and resulting in better self-care, thus, it may influence 
individual´s HRQoL. A retrospective survey by Sirri et al (2011) found that social support is 
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positively related to physical and social dimensions of HRQoL measured by World Health 
Organization Quality of Life-Bref (WHOQL-BREF) in long term survivors of 66 cardiac 
transplant [29]. In addition, the descriptive cross sectional surveys demonstrate that social 
support measured by the Social Support Questionnaire is an important factor affecting a general 
cancer specific HRQoL in patients with cholangio carcinoma  (n = 260) [136] and   
gastrointestinal cancer (n = 146) [137]. A comparative study demonstrate that social support 
measured by The Enhancing Recovery in Coronary Heart Disease Patients Social Support 
Instrument has a significant relationship with cancer specific HRQoL in 175 men treated with 
localized prostate cancer [138].  Luszcynska et al (2007) found that social support is 
significantly associated with physical functioning as measured by the SF-20 (physical 
component) in 104 patients infected with HIV [125]. A descriptive study of 118 patients infected 
with HIV report significantly positive relationships between social support and all subscales of 
HRQoL except bodily pain and tangible support [139]. Patients with breast cancer demonstrate 
positive relationship between social support and HRQoL [84]. Furthermore, a cross sectional 
study of Carlsson found that a sample of individuals at risk for hereditary cancer attending 
genetic counseling has significantly positive association between social support and mental 
component scores [8].  
Research has shown that social support is associated with less stress [133-135] and social 
support appears to have a positive effect on adjustment following treatment [87]. Social support 
influences the cognitive appraisal of stressful encounters by helping to mitigate the effect of 
stressful events and HRQoL. Coping then, is a result of the cognitive appraisal of tangible 
support availability [97]. The subscores appraisal and self-esteem by Interpersonal Social 
Evaluation List, were related to better emotional HRQoL in patients attending genetic 
counseling for hereditary cancer, [8]  and  in patients with breast cancer [84], indicating a 
moderating effect of social support on mental HRQoL. As stress, measured by The Perceived 
Stress Scale, mediates the effect of Enhancing Recovery in Coronary Heart Disease Patients 
Social Support on HRQoL (measured by The Functional Assessment of Cancer Therapy-
General, FACT-G) in men treated for prostate cancer [138], it is likely that social support may 
mediate stressful life events [86]. In summary, some studies have shown that social support is 
positively related to HRQoL across disease settings. However, no studies have evaluated the 
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association between social support and HRQoL in  patients with NET. Feedback from patients, 
friends or family highlights the person’s capabilities, thus, social support may be an important 
part of the individual’s resources in the coping process.  
5.2.4 The associations between stress, general self-efficacy, social support and 
health related quality of life. 
Researchers have evaluated associations between stress, self-efficacy, social support and 
HRQoL and found that stress associated negatively with HRQoL. In addition, those with more 
social support and self-efficacy had better HRQoL. A study of women with breast cancer and 
low levels of social support measured by Appraisal support, there was a significant negative 
relationship between cancer-related intrusive thoughts and HRQoL. However, for those with 
high levels of social support, the cancer-related intrusive thoughts were not significantly related 
to HRQoL. Furthermore, social support acted as a buffer to stressful life events in women with 
breast cancer (n = 179) in a descriptive study [140]. In a descriptive cross sectional study of 260 
patients with gynecological cancer, social support appeared to protect patients from traumatic 
stress symptoms associated with poor physical HRQoL [141]. These results suggest that 
appraisal social support can mitigate traumatic life events in patients with cancer [84]. However, 
while emotional support did not protect against stressful life events as measured by a mental 
health inventory in patients with breast cancer, tangible support did [140].  
Self-efficacy may act as a self-regulating process by reducing the discrepancies between stress 
and mental HRQoL [86;142]. Carlsson (2004) found that stress, social support and general self-
efficacy had a direct negative relationship with mental HRQoL in individuals at risk for 
hereditary cancer (n =121). In addition, general self-efficacy and social support (by appraisal 
and self-esteem) seemed to moderate the association between stress and mental HRQoL 
analyzed with multiple linear regression [8]. No mediation effect was investigated thus; 
mediation was evaluated in this study.  
In summary, there is evidence that general self-efficacy and social support have a positive 
relationship with HRQoL while stress has a negative impact on HRQoL.  However, the results 
are inconsistent and no studies have investigated the association between general self-efficacy, 
social support, stress and HRQoL in patients with NET. In addition, no studies have evaluated 
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the mediation effect of general self-efficacy and social support on the association of stress and 
HRQoL.  
5.3  Patient education to improve stress, general self-efficacy and health 
related quality of life  
 Stress is regarded as a symptom in response to a specific stressor [88] and may influence the 
patients’ adaptation to  disease  and thus their HRQoL [5;8-11]. Consequently, stress might 
influence the patients’ physical and mental functioning. Interventions aimed at increasing 
patients’ ability to cope with stress may be a complimentary treatment option. A randomized 
controlled trial (RCT) of patients with gynecological cancer (n = 179) demonstrated reduced 
stress and improved HRQoL following an individual support intervention led by nurses and 
psychologists [143]. The intervention was based on the principles of cognitive restructuring 
techniques as applied to cancer related issues, identifying support, coping with effect of 
treatment [143]. In addition, a RCT aimed to reduce stress among women (n = 353) with 
gynecological cancers demonstrated significant reduction over time [144]. The intervention 
considered seven hour-long individual and one telephone booster session that took place 1 week 
after the sixth session. The sessions focused on enhancing coping and support-solicitation skills 
and identifying and dealing with emotional reactions to cancer. Techniques were drawn from 
cognitive-behavioral interventions.  
Previous RTCs have found moderate, positive impact on chronicity-specific self-efficacy in 
chronically ill patients [145]. An educational program aimed at delivering support for self-care 
by developing peoples self-care skills, confidence and motivation to take more effective control 
over their long-term conditions improved self-efficacy. A caveat was that the educational 
program appealed most to white, middle class people with long-term conditions who already 
viewed themselves as effective self-managers [145]. A waiting list RCT reported statistically 
significantly improved chronicity specific self-efficacy in 154 chronically ill Vietnamese and 
Chinese patients but was not helpful in Greek and Italian populations [146]. The intervention 
consisted of six weekly sessions of 2.5 hours duration using the Chronic Disease Self-
Management Workshop Leaders manual. The patients were taught symptom management, 
problem solving, dealing with the emotions of chronicity, exercise and relaxation, use of 
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medication, healthy eating, and communication skills. The intervention was based on the four 
principles of self-efficacy; mastery experience, vicarious experience, verbal persuasion, and 
strengthened physical and affective state [146]. In another RCT, Buszewicz [38] significant 
differences were noted for the pain subscore of the arthritis self-efficacy scale and self-efficacy 
for other aspects of management after 12 months in 812 patients with arthritis, following an 
intervention based on the principles of self-efficacy. The intervention consisted of an education 
booklet, and an invitation to participate in a local “challenging arthritis” course. The booklet was 
not described, but was designed for the study and incorporated information available to the 
public from the Arthritis Care and the Arthritis Research Campaign. 
Interventions including self-management often results in improved health outcomes for patients 
with chronic conditions [147] and  cancer [148]. Several studies have reported on HRQoL 
outcomes, assessed by a variety of domain specific measurements following an intervention 
based on social cognitive theory principles [35;44;145;146;149-151]. A review of studies of 
patients with cancer undergoing an intervention based on the principles of self-efficacy found 
positive changes in domain specific quality of life [36]. Rehse and Pukrop (2003) reviewed the 
effect of psychosocial interventions on quality of life in adult cancer patients.  Twelve percent of 
the studies referred include support groupswhich provided mutual help. The most important 
aspects of the intervention were emotional support and coping skills training. Fifty-four percent 
of the studies used cognitive behavioral or behavioral methods to modify cognitions of specific 
coping skills. In addition, minimal differences in HRQoL could be observed when an 
intervention lasted for at least 12 weeks [37]. A meta analysis of RCTs among cancer patients 
demonstrate improvements in physical function and global quality of life following  
psychosocial interventions [36]  based on Bandura’s social cognitive theory. McCorcle found 
improvements in mental and physical components of HRQoL (SF-12) following a 6 months 
RTC to improve self-management skills in women with 123 gynecological cancers [149]. The 
primary aim of the intervention was to assist patients in developing and maintain self-
management skills after surgery and to facilitate their active participation in decision-making 
with regard to treatment. The intervention included symptom management and monitoring, 
emotional support, patient education, coordination of resources, referrals and direct nursing care 
over 18 patient contacts. In a RCT evaluating mental and physical components of HRQoL in 
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patients with arthritis, Buszewicz [38] found no  significant differences between the intervention 
group and the control group. The intervention aimed to evaluate clinical effectiveness of a self-
management programme for patients in primary care with osteoarthritis consisted of an 
education booklet and an invitation to participate in a local arthritis course. The controls 
received only the education booklet. A controlled study including breast cancer patients (n = 65) 
attending support groups did not show significant improvements of social support measured by 
The Social Support Questionnaire and cancer specific HRQoL. The intervention included 
information on illness and treatment and relaxation. Patients met for 2 hours twice a week for 
four weeks [152].   
In summary, lack of standardization of interventions, differences in disease trajectories, 
variations in chronic vs. acute conditions, and inconsistent prior findings on the relationship 
between to stress and Quality of Life provide the rationale for this study.  
6. The study  
6.1  Design, recruitment, participants and measurements 
 A cross sectional descriptive, survey design was used for Phase I of the study (Papers I and II) 
and an explorative, longitudinal design of three points in time (T1 - T3) was used for Phase II 
(Paper III).  Recruitment of two different samples was collected in order to perform the studies.   
6.1.1 Data collection  
A cross-sectional design using survey methodology with anonymous, self-reported 
questionnaires was employed in Phase I. 
Participants for the cross sectional, descriptive survey (Papers  I &II) 
All NET centers nationwide (University Hospital Haukeland HF, University Hospital in the 
North of Norway HF, Oslo University Hospital HF, University Hospital Trondheim HF) 
identified and mailed information about the study and questionnaires. Inclusion criteria were: 
x Undergoing medical treatment for NET  
x Tumors restricted to the GI tract  
x Ability to read, speak and write in Norwegian  
x Age ≥ 18 years 
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Exclusion criteria were:  
x Terminally ill  
x History of radical surgery that may have been curative  
x Diagnosed with cognitive or mental dysfunction  
Of two hundred and sixty-one patients who were diagnosed and treated for NET , 236 patients 
were eligible in June 2007. Twenty-five patients met the exclusion criteria, which were assessed 
by their physicians. One hundred ninety-six (83%) patients returned the questionnaire after one 
reminder. Consent was assumed with return of the survey. 
 General Population Sample 
The data from the Norwegian Survey of Living Conditions served as controls and were collected 
in 2002 and are available through Statistics Norway [153]. We collected demographic data and 
data from the Quality of life (SF-36) survey. The Norwegian Social Science Data Services 
mailed the survey to a random sample of individuals over 18 years of age [153]. Six thousand 
eight hundred and twenty-seven individuals (age range 15 – 103 years) answered the 
questionnaire (SF-36) during the period of October 2002 to February 2003, a response rate of 66 
%. Respondents in the same age range as the patients with NET (23 – 85 years) were included (n 
=5152).  
Participants for the exploratory study (Paper III) 
The 26 week exploratory study was employed in Phase II and used a single-group pre- test post-
test design at three different assessment points (T1-T3): two weeks before (T1), two weeks after 
(T2) and 6-months after (T3) enrollment in a patient education intervention.  
The exploratory study took place at three of the five Norwegian regional University Hospital 
NET centers (Bergen, Trondheim and Oslo). The sample included NET-patients. Enrollment 
occurred at the clinic where the patients were referred. Additional inclusion criteria compared to 
the cross sectional survey was that the patients had to be diagnosed with NET within the last 24 
months. 
The patients were mailed information about the study and a questionnaire and a stamped 
envelope after informed consent was given to the NET centers.  The patients were sent 
questionnaires by mail from the referral hospital with a stamped envelope to return documents. 
Those who did not return the questionnaire within 2 weeks received a reminder letter by mail. 
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The study was conducted from September 2005 to December 2007.  
Participants 
One hundred-and-thirty-seven (n = 137) subjects met inclusion criteria.  Of these, 96  (n = 96, 
response rate 70%) declined to participate. No data were collected from those who declined to 
participate.  
Forty-one patients with NET were enrolled (n = 41, response rate 30%, 51% male).  Two 
patients dropped out and two died prior to T2. Measures were completed two weeks after start 
up of the intervention  (T2). Thus, 37 patients completed the 26 weeks intervention. Twenty-
nine patients (n = 29, response rate 71% of the enrolled patients) returned the questionnaire at 
six months following the patient education intervention start up (T3) due to lost to follow up (see 
Flow diagram).  
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6.2  Patient education intervention  
The 26 Week Intervention 
The intervention was inspired by Bandura’s Social Cognitive Theory focusing on self-efficacy 
[90]. Social cognitive theory is based on the assumption that patients are the principal agent in 
shaping and responding to environmental conditions, and consequently, are able to acquire new 
skills and competencies, take part in their self-development, and adapt as needed. Focusing on 
the patients’ strengths and capacities to utilize supportive relationships and think critically may 
enable the patients to cope with cancer related-stress and thus improve HRQoL [61].  
Strategies for enhancing self-efficacy incorporate 1) Mastery experience which includes 
considering and utilize previous successful performances; 2) Vicarious experience, or modeling 
others, involves watching someone else in a similar situation who has had success in performing 
activities; 3) Verbal persuasion is encouraging patients to believe that they have the ability to 
achieve their goals and; 4) Strengthening physical and psychological state includes teaching the 
patients about their disease  and psychological reactions to  severe illness [32;33]. 
The intervention consisted of 10 sessions over a period of 26 weeks. The intervention consisted 
of lectures, group discussions and individual telephone calls in two phases  (Intervention Table). 
All group discussions and individualized telephone calls were facilitated by a total of six nurses 
specialized in patients with NET. The first phase took place over four consecutive days and 
included lectures and group discussions. All patients participated in a 45-minute orientation 
session to introduce them to study protocols, goals, and the principles of general self-efficacy. 
During the introductory session, patients received a booklet containing the intervention protocol. 
During the next four days, 45 minute didactic sessions were conducted in  the morning followed 
by a 60 minute group discussion. The purpose of the morning sessions was to improve the 
patents’ knowledge of NET, side effects of medication and treatment and what to expect in the 
follow visits. In the afternoon, the patients underwent motivational training and goal setting 
exercises. Motivational training included empathetic guidance in goal-setting, specific and constructive 
questioning on patient priorities and, supporting constructive alternatives if barriers were encountered in 
setting goals. Writing goals and discussing how to best achieve goals based on previous 
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experiences accomplished mastery. The participants were instructed on ways to break down 
larger goals into smaller, weekly action plans that were measureable, realistic and attainable. 
Vicarious learning was modeled on other patients’ successful self-care activities. In addition, the 
patients were trained on how to encourage each other in self-efficacy thoughts. A strategy to 
strengthen physical and physiological state was accomplished through information about NET.  
Content of information included knowledge of the illness trajectory and how to respond on 
symptoms. This facilitated the implementation of appropriate actions when needed and avoided 
setbacks. In addition, patients learned when it was appropriate to contact their physician or 
oncology nurse. 
 The second phase lasted for 24 weeks and included 6 follow – up group discussions and 
18 individual telephone calls. All group discussions and individualized telephone calls were 
facilitated by a total of six nurses specialized (nurse) in patients with NET. Patients met at the 
NET centers at their regional hospitals for 90 minutes group discussion every four weeks. Four 
to six individuals took part in each group discussion. Weekly telephone calls (45 minutes) were 
conducted between the group meetings. Motivation and training was led by the nurse who 
assisted patients in achieving their goals by giving positive feedback and focusing on their 
strengths and success. The nurse also encouraged patients to share previous successful 
experiences with each other as well as taking part in social activities in order to build supportive 
relationships. 
To ensure adherence to the intervention, the principal investigator trained the nurses on how to 
apply the principles of self-efficacy during three 45-minutes sessions and in additional booster 
sessions. The nurses performed a critical self-evaluation after every group session by reflecting 
on how the four principles of self-efficacy had been discussed and supported and how they used 
the principles in clinical practice during the group sessions and individual talk.  Reflections were 
then logged for follow-up discussion with the principal investigator. In addition, the principal 
investigator was available for counseling the nurses at any time if the nurses needed guidance. 
The nurses received a training booklet to refer as needed. The booklet contained information 
about the purpose with the group session, and how to prepare for the group session. The booklet 
also contained information about social cognitive theory, how to utilize the principles of self-
efficacy, and offered suggestions for the group sessions. Finally, the booklet included action-
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plans and how to use them.  
The Intervention Table is included in the thesis to illustrate the main topics of the patient 
education intervention.  
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Intervention Table. Description of the phases, the content and the responsible persons in the 26-week 
patient education intervention  
Phase    Content      Responsible Person 
Phase 1 
Week 1 
 Introduction 
(1 x 45 min) 
x Study protocol, information about goal 
setting and information about principles 
of self-efficacy. The patients received a 
booklet with the intervention protocol to 
take home. 
x The principal investigator 
 
  Discussion  
(16 x 45 min) 
x Disease specific knowledge 
x Psychological reactions on severe illness  
x Social rights  
x Physical activity  
x Nutrition  
 
x Physician 
x Psychologist 
x Social worker 
x Physiotherapist 
x Nutritionist 
 Group 
sessions  
(4 x 60 min) 
Discussions based on the principles of 
self-efficacy in order to enhance  
problem solving strategies: 
x Mastery experiences: Utilize 
previous, optimistic and positive 
experiences and evaluate their 
written goals 
x Vicarious experiences: Utilize 
significant other’s optimistic and 
positive experiences in the coping 
process  
x Verbal persuasion: Encourage 
participants to believe  they could 
achieve their goals, share 
experiences,  and support each 
other’s coping strategies 
x Strengthen physical and 
psychological state: Utilize disease 
specific knowledge and enable the 
patients to recognize disease 
specific symptoms and when to 
contact health care for assistance 
 
x Nurse 
Phase 2 
Week  
2 – 26 
 Group 
sessions  
(6 x 90 min) 
Discussions based on the principles of 
self-efficacy in order to enhance  
problem solving strategies: 
 
x Nurse 
 Individual 
telephone 
calls  
(18 x 30 min)  
x Individual support based on the 
principles of self-efficacy: follow up of 
weekly goals and reflective notes  
x Nurse 
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6.3 Measures 
6.3.1 Demographic and disease related variables 
The following demographic data were obtained by questionnaire: age (continuous variable in 
years), gender, marital status, education  (primary: < 10 years, high school: 10-13 years, 
secondary education:> 13 years), working status (full-time, part-time, retired), income 
(continuous variable in Nowegian currency; NOK),  time since diagnosis (continuous variable), 
symptom frequency (yes/no, diarrhea, fatigue, nutrition intolerance, flushing, restlessness, 
fluctuation in  mood, and individually specified symptoms). 
6.3.2 Short form 36 (SF-36) 
The SF-36 was developed in the United States as part of   the Medical Outcomes Study to assess 
satisfaction with medical care [78]. The questionnaires consist of 36 items scored on Likert type 
scales [78].  The instrument measures eight dimensions of health including: physical function, 
physical role limitations, bodily pain, general health, vitality, social functioning, emotional role 
limitation, and mental health. Item scores are transformed into scales ranging from 0 to 100. 
Higher scores indicate better subjective health status. The eight scores may also be transformed 
into one mental and one physical component scores. The mental component scores of SF-36 are 
based on scores for vitality, social functioning, emotional role limitations and mental health.   
The physical component scores are based on the physical function, physical role limitations, 
bodily pain and general health subscores [78;154]. The questionnaire has shown satisfactory 
reliability, validity and responsiveness to changes in health status across a broad spectrum of 
cancer patients and other patient populations, including Norwegian populations [155]. The 
reliability of the scale estimated by Cronbach´s alpha is shown in Table 3. 
6.3.3 Impact of Event Scale  
The impact of event scale (IES) is a questionnaire developed by Horowitz et al that assesses 
current subjective stress related to a specific event [88]. The measurement is sensitive to change 
over time and thereby useful in assessing progression of stress. A modified version of Impact of 
Event Scale was used to measure current subjective stress specifically related to NET. The IES consists 
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of 15 items, 7 of which measure intrusive symptoms (invasive thoughts, nightmares, invasive 
feelings and imaginary), 8 tap avoidance symptoms (numbing of responsiveness, avoidance of 
feelings, situations, ideas) and combined, provide a total subjective stress score [88]. 
Respondents are asked to rate the levels of stress on a six point Likert scale ranging from 0 
(never) to 5 (often) according to how often each has occurred in the last week. The total score 
ranges from 0 to 75 and a higher score indicates a higher impact from stress. The IES has been 
translated into  different languages, and has shown satisfactory reliability, validity, sensitivity 
and responsiveness [88], including in Norwegian cancer populations [8;10]. The reliability of the 
scale estimated by Cronbach´s alpha is shown in Table 3. 
6.3.4 General self-efficacy 
The General Perceived Self-Efficacy Scale (GSE) is a questionnaire developed by Schwarzer at 
the Freie Universität in Berlin [96]. The GSE Scale is a ten item scale in which people judge 
how able patients are [156]. Each item is scored from one (quite wrong) to four (quite right). 
The summary score ranges from 10 to 40, where the highest score indicates high self-efficacy. 
The scale has demonstrated validity and reliability across cultures [96;156]. The reliability of the 
scale estimated by Cronbach´s alpha is shown in Table 3. 
6.3.5 Interpersonal Support Evaluation List 
The Interpersonal Support Evaluation List (ISEL) was developed by Cohen  & Hoberman [86] 
and was intended to be used with a general population sample. King and colleagues modified 
and used the measure in long-term recovery patients after coronary artery bypass surgery [157]. 
The questionnaire has five subscales; appraisal support, self-esteem support, group belonging, 
emotional closeness and tangible aid (Paper II). Also, an average total sum score may be used 
[86]. The items in the measure are scored from 1(definitely true) to 4 (definitely false), where 
the highest score indicate high social support  [86]. The reliability of the scale estimated by 
Cronbach´s alpha is shown in Table 3. 
6.4  Data analysis and statistical methods 
Descriptive analyses (mean, median, percentages, SD, range) were performed to assess the 
characteristics of the respondents (Paper I, II, III) and outcome measures of stress, general self-
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efficacy, PCS and MCS (Paper III). Chi-square tests were performed to examine for differences 
in categorical data and Analysis of Variance (ANOVA) were used  to investigate differences in 
characteristics of the responders (Paper I and II). Post-hoc Bonferroni correction was performed 
in order to adjust the level of significance for the number of simultaneous comparisons of 
variables (Paper I). T-tests were performed in order to examine the differences in the means in 
the subscales of SF-36 across the samples.  Effect size for differences in HRQoL between 
patients with NET and the general Norwegian population (Paper I) was calculated to assess the 
clinical relevance of the difference between the two samples. In addition, effect sizes for 
changes in stress, general self-efficacy and HRQoL  (Paper III) was calculated to assess the 
clinical relevance of the changes of the variables. According to Cohen’s classification for 
differences in means, a small effect size ranges from 0.2 to 0.49, a moderate from 0.5 to 0.79 
and greater than 0.8 as a large [158]. Bivariate analyses (Pearson’s r) was used to investigate 
possible associations between continuous variables (Paper II) aiming to determine the strength 
and direction of the relationship between the variables; gender, age, marital status, education, 
disease duration, physical component scores, mental component scores, stress, social support 
and, general self-efficacy.  Cohen guidelines suggest a small association to be r = 0.1 to 0.29, a 
moderate from r = 0.3 to 0.49 and a large r = 0.50 to 1.0 [159] (p. 79-81).  
To be able to predict the value of the dependant variable HRQoL (mental and physical HRQoL) 
we described the relationship between a continuous, dependent variable and one or more 
(continuous or categorical) independent variable (predictors, explanatory variables or covariates) 
by performing multiple linear regression analyses (Paper II). The specified regression models 
were based on the assumption of associations identified by previous research. Selected 
demographic variables were used as possible confounders as well as social support, general 
perceived self-efficacy and stress. Mental and physical component scales of Health related 
quality of life was entered in the regression analysis as the two dependent variables.  
Due to the small sample size, we constructed mixed effect models (individual growth models)   
to evaluate overall changes in stress, general self-efficacy and HRQoL from T1 to T3 (Paper III, 
Table 4). Mixed effect models   integrate analysis of individual within-patient trajectories as 
well as differences across trajectories between patients [160]. This technique overcomes some of 
the limitations of traditional repeated measure analysis of variance (ANOVA), such as the 
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requirement of balanced data with all individual parameters measured at each of the three time 
points. The analysis does not require list-wise detection of missing data. These analyses enabled 
estimation of average within-patient change over time in our primary outcome measures of 
stress, general self-efficacy and HRQoL as well as the rate of change across patients. In all 
analyses, we accounted for age, gender, symptoms and co-morbidity. For each of the 
explanatory variables effects of interaction with time were evaluated separately. Gender, as well 
as baseline age and co-morbidity, were held constant across time and were considered fixed 
predictors in our models. The presence of one or more symptoms changed over the three points 
in time and was included as  time  variables. Given the small sample size, we used time (T1, T2, 
T3) as a linear variable. As average change in stress deviated from linearity, we also ran the 
model using time as a categorical variable, which led to the same conclusion.  
Mixed-effect models differentiate the total variance of the outcomes measures into within-
patient variance and between-patient variance. Within-patient variance includes random error as 
it varies across the three time points. Between-patient variance indicates the variation in baseline 
(intercept) and the variation in rate of change (slope) between patients. In addition, the 
covariance between intercept and the rate of change is estimated and may, for example, indicate 
higher rate of change in patients with low baseline scores [160].  
The growth curve modeling for each of the outcome measures, stress, general self-efficacy and 
HRQoL in Paper III consisted of two steps. In the first step, between-patient differences in 
baseline (T1) scores were modeled, i.e. the random intercepts, estimating the average within-
patient change as well as the difference in rate of change across patients (random slope) (Paper 
III, Table 3). In the second step, the extent to which the specified explanatory variables; age, 
gender, co-morbidity and symptoms, accounted for any differences in rate of change in each of 
the three outcome variables were assessed. For each of the explanatory variables effects of 
interaction with time was evaluated. Gender, as well as baseline age and co-morbidity, was held 
constant across time and was considered fixed predictors in our models. The presence of one or 
more symptoms was considered as a time varying explanatory variable.  Average change in 
stress deviated from linearity, thus, we ran the model using time as a categorical variable, which 
led to the same conclusion. 
The level of statistical significance was set at 0.05 for all analyses. Cronbach’s coefficient was 
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assessed to confirm internal consistency reliability for all measurements. Acceptable levels were 
considered to be  > 0.70 [159]. Effect size (ES) of differences between the sample of patients 
with NET and the general norm population and the changes in stress, general self-efficacy and 
HRQoL were calculated in order to estimate and interpret clinical meaningful changes. Effect 
size was computed as differences in mean scores divided by the pooled standard deviation [159]. 
SPSS version 15 was used for the statistical analysis. 
6.5  Power analysis  
A RTC design was planned for Phase II of this study. Power analyses were conducted in order to 
determine sample size. Power to detect a difference between the intervention and control groups 
was calculated to be 3 points for SF-36 mental component scores, mental health (MH) and social 
functioning (SF) based on results from Dysvik et al [161].The analyses in the study were 
repeated t-tests. Although we may suggest that  the eight SF-36 subscores  will change 
differently following the intervention, researchers indicate that changes of 5 points may be 
considered clinically important [71;161]. Seventy-three patients are needed in the present study 
given a standard deviation (SD) of 15, a power of 80 % and a significance level of 0.05 %. The 
estimation of the power matches an effect size of 0.33, which matches the changes of MH and 
SF in Dysvig`s study. However, identification of patients was not possible due to the lack of a 
consistent national identification code for the diagnosis of NET. Although codes for 
identification of diagnosis related group (DRG) are used for billing in most all regional 
hospitals, the DRGs’ for Norwegian patients with NET are not consistent.  In addition, due to 
the lack of concentration of patients in the country and the limited number of patients  with NET 
meeting eligibility criteria, a randomized controlled design was not feasible.  Thus a single 
group, exploratory design was employed to evaluate the changes in stress, general self-efficacy 
and HRQoL (Paper III). A convenient sample was chosen for the study. We identified 137 
patients through a period of two years and 41 patients were enrolled in the study.   
For the cross sectional survey (Paper I, II), we decided to include all the identifiable patients 
from the NET centers nationwide. As the inclusion criteria in the cross sectional surveys had no 
limitation for the disease duration, we ended up with 236 eligible patients and 196 patients 
responded.    
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6.6  Ethical considerations 
Research involving humans requires a careful consideration of the procedures to be used in 
protecting the rights of the participants. Ethical principles in research include the principles of 
respect for human dignity, justice and beneficence. Exposure to emotional questions may be a 
distressing experience. An adverse effect of the study could be that the patients were asked 
emotional questions, in particular questions in the stress and general self-efficacy instrument. 
The participants in this study may be considered a particularly vulnerable population as they 
often suffer, experience adverse symptoms as well as stress. In order to avoid asking vulnerable 
patients to participate in the study, the patients’ conditions were discussed with the physician 
specialist to ensure that the patients were not too critically ill.  We followed the Declaration of 
Helsinki: Ethical Principles for Medical Research Involving Human Subjects [12],  that requires 
that the well-being of human subjects must outweigh scientific interests. In addition, the nurse 
had the possibility of contacting the physician or the researcher responsible if they detected 
symptoms of stress related to the burden of attending the study. 
 The Regional Ethics Committee in Health Region II (South) of Norway (S-05156) and the 
Norwegian Social Science Data Services approved the study (1823) and (2005/AS/PVO-FO-
001). Consent from the patients was assumed with the return of the survey in the cross sectional 
study, and patients were informed that they could contact the project investigator or more 
information. Patients who met the inclusion criteria in the exploratory study returned a signed 
informed consent.  
The patients received information about the study and they were invited to question the project 
investigator and the nurses at enrollment.  To enhance informed consent the project investigator 
took extra time to explain the project, clarify the patients’ understanding of the booklet and 
emphasize the voluntary nature of the research. The project investigator also gave repeated 
reminders of the right to withdraw or to stop answering the questionnaires throughout the study. 
Two patients withdrew after enrollment.  
Response burden may be of particular relevance to patients with NET in that they experience 
fatigue and/or weakness. Thus, we considered the amount of instruments as well as the 
importance of brief questionnaires in selecting instruments. In addition, the questionnaires may 
cause psychological distress by reminding patients of their health problems. The participants in 
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the study were instructed to contact health care personal if they needed support during the study. 
We provided contact through a particular telephone number answered by a nurse from the 
intervention team. No participants reported fatigue or distress from participating in the study. 
7. Results 
7.1 The characteristics of the study sample  
Characteristics of socio demographic and disease specific variables used in the cross sectional 
survey (Paper I, II) and exploratory study (Paper III) are presented in Table 1. Description of the 
average Mental (MCS), Physical (PCS) Component scores and subscores of SF-36, Stress (IES), 
Social support (SS), General Self-efficacy (GSE) and standard deviation (SD) of the participants 
in Paper I, II (n = 196) and the baseline data of the subjects in Paper III (n = 41) appear in Table 
2. Description and reliability scales and subscales used when evaluating cross sectional data  
(Paper I, II) and longitudinal explorative data (Paper III) are presented in Table 3. 
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Table 1. Characteristics of sociodemographic and disease specific data used in the cross 
sectional survey (n = 196) (Paper I,II) and the longitudinal survey (n = 37) (Paper III) 
 
 
 
Demographic and disease 
specific variables 
Paper I,II Paper I,II Paper III Paper III 
 N (%)  N (%)  
Disease duration  
 Years mean (range) 
Months mean  (range) 
  
4.8 ( 0-23) 
  
 
13 (1-24) 
Gender     
Male   97 (49.5)  17 (46)  
Female  99 (50.5)  20 (54)  
Age mean  65 (33-85)  60 (61, 36-80)  
Marital status     
Single, divorced, 
widowed  
49 (25)  
9 (24) 
 
Married, 
cohabitation  
147 (75)  
28 (76) 
 
Employed     
Working a 54 (28)  13 (38)  
Retired, pension b 97 (50  21 (62)  
     
Education years      
< 10 years 72 (41)  10 (27)  
10-13 years 47 (27)  11 (30)  
>13 years 57 (32)  16 (43)  
Income NOK  246 000 (229 000, 
0-780 000) 
 542 000 (303 000, 100 
000 – 4 500 000) 
 
Treatment     
Interferon  32 (16)    
Somatostatin 
analogue n (%) 
102 (52)    
Combination of 
different 
somatostatin 
analogues  
17 (11)    
Chemotherapeutics 
n (%) 
10 (5)    
No treatment  37 (19)    
Symptoms frequently c     
Diarrheae  98 (50)  13 (36)  
Fatigue 97 (49)  13 (36)  
Nutrition intolerance 9 (5)  33 (91)  
Flushing  23 (12)  7 (19)  
Restlessness  38 (19)  7 (19)  
Fluctating mood  41 (21)  11 (30)  
Others  24 (12)  3 (8)  
Co-morbidity (numbers) 179 (91  11 (31)  
Mean (SD/range)  3.4 (2, 0 – 11)  0.5 (0.5, 0 – 5) 
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Table 2. Mental (MCS), Physical (PCS) Component scores and subscores of SF-36, Stress (IES), 
Social support (SS), General Self-efficacy (GSE) and standard deviation (SD) for Paper I, II, III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mental and physical Components score: Standardized Mean50, SD = 10 
Abbreviations: SF-36 Subscale scores PF: physical functioning; RP: role physical ; BP; bodily pain; GH; general health; VT: 
vitality; SF: social function; RE: role emotional; MH: mental health. 
SF-36 subscale score  = 0 -100,  
IES: Score 0-75 
SS: Score: 0-4 
GSE: Score: 10-40 
Higher scores indicate better PCS, MCS, GSE and SS and SF-36 health related quality of life  
Lower score indicate less stress (IES). 
Paper I, II III, Baseline Mean (SD)  III, T2 Mean (SD)  III, T3 Mean (SD)   
SF-36 
MCS 
 
39.6 (11) 
 
43.3 (9.3) 
 
43.9 (10.7) 
 
43.7 (12.1) 
 
PCS 
SF-36 
PF 
RP 
BP 
GH 
VT 
SF 
RE 
MH 
 
IES 
SS 
GSE 
45.9 (11.4) 
 
87.3 (19) 
77.7 (37) 
74.2 (26) 
78.8 (20) 
60.9 (20) 
86.8 (21) 
84.9 (32) 
80.3 (15) 
 
24.3 (16) 
3.1 (0.5) 
29.9 (5.5) 
42.1 (10.1) 
 
 
 
 
 
 
 
 
 
 
26.5 (13.6) 
3.3 (0.5) 
31.2 (3.2) 
44.8 (8.5) 
 
 
 
 
 
 
 
 
 
 
23.3 (14.3) 
3.3 (0.6) 
32 (3.8) 
45.7 (9.1) 
 
 
 
 
 
 
 
 
 
 
24.1 (14.8) 
3.3 (0.5) 
32.3 (3.7) 
 
 
 
42 
 
 
 
 
Table 3. Description and reliability of scales and subscales used in the cross sectional study (N= 
196) and the exploratory study (N=39) 
 Instrument Scales Items  Total 
range 
(mean) 
 Chronbach’s 
alpha 
    Paper 
I 
Paper II Paper 
III 
Health Related Quality of 
Life (SF-36, 8 subscales) 
 
 
 
 
 
 
 
Physical Health Summary 
Score (SF-36) 
 
 
 
Mental Health Summary 
Score (SF-36) 
 
Physical Function 
Role Physical 
Bodily Pain 
General Health 
Vitality 
Social Functioning 
Role Emotional 
Mental Health 
 
 
Physical Function 
Role Physical 
Bodily Pain’ 
General Health 
 
Vitality 
Social Functioning 
Role-Emotional 
Mental Health 
10 
4 
2 
5 
4 
2 
3 
5 
 
21 
10 
4 
2 
5 
14 
4 
2 
3 
5 
0-100 
0-100 
0-100 
0-100 
0-100 
0-100 
0-100 
0-100 
 
(50) 
0-100 
0-100 
0-100 
0-100 
(50) 
0-100 
0-100 
0-100 
0-100 
0.93 
0.90 
0.92 
0.78 
0.83 
0.82 
0.86 
0.88 
 
 
 
 
0.93 
0.90 
0.92 
0.78 
0.83 
0.82 
0.86 
0.88 
 
0.93 
 
 
 
 
0.89 
 
 
 
 
 
 
 
 
 
0.93 
 
 
 
 
0.87 
 
 
General Self Efficacy 
(GSE) 
Total summary 10 10-40  0.87 0.84 
 
Perceived Social support 
(ISEL) 
Appraisal Support  
Self-esteem Support 
Group belonging 
Emotional  
closeness 
Tangible Aid 
6 
6 
6 
6 
6 
1-4 
1-4 
1-4 
1-4 
1-4 
 0.76 
0.63 
0.69 
0.67 
0.91 
 
Stress (IES) Intrusion 7 0-35  0.86 0.83 
Avoidance 8 0-40  0.83 0.79 
 
 
 
7.2  Sample characteristics for the cross sectional studies (Paper I, II) 
The main age of the responders were 65 years (range 33 – 85), and the percentage of men was 
49.5. The median duration since diagnosis of NET was 4 years (range = 0 to 23), 68 % of the 
patients had a high school education, 75 % were married or living with partner and 50 % were 
retired or were receiving a  disability pension (Table 1). The mean scores for stress was 24.3 
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(SD = 16), for social support 3.1 (SD = 0.5) and for general self-efficacy was 29.9 (SD = 5.5) 
(Table 2). 
7.2.1 Health related quality of life among patients with neuroendocrine tumor 
compared with the general Norwegian population (Paper I).  
The aim of the paper was to describe the HRQoL among a nationwide sample of patients with 
NET compared to the general Norwegian population. Of the 196 patients with NET, better 
physical functioning was associated with lower age, educational levels above 16 years and 
working part time or more. Also, patients younger than 60 years of age and those working part-
time or more demonstrated statistically significant fewer role limitations physical compared with 
those above 60 years of age and those who were retired or pensioned (Paper I, table 1).  
Results showed that patients with NET scored significantly lower on all SF-36 subscales (P< 
0.001) except for bodily pain (p = 0.017) than the general Norwegian population. The largest 
difference were in general health (d = 0.84), role limitations physical (d= 0.57) and vitality (d = 
0.51) (Paper I, Table 3).  
7.2.2 Associations between stress, social support, general self-efficacy and HRQoL 
in patients with NET (Paper II).  
This paper aimed to explore the association between stress, general self-efficacy, social support 
and HRQoL. We also evaluated if general self-efficacy and social support mediated the 
association between stress and HRQoL.  
The main effect model that evaluated the association between general self-efficacy, social 
support, stress and HRQoL showed that higher stress was associated with poorer mental HRQoL 
(Beta = -0.54, p<0.001). Higher social support (Beta = 0.41, p<0.001) and higher general self-
efficacy (Beta = 0.49, p<0.001) were related to better mental HRQoL (Paper II, Table 3). 
Additionally, in a similar model for physical HRQoL, stress was negatively related (Beta = -
0.20, p = 0.01) (Paper II, Table 3) whereas general self-efficacy was significantly associated 
with better physical HRQoL (Beta = 0.37, p = 0.03).  
Evaluation of the mediating effect of social support on the relationship between stress and 
mental HRQoL is shown in Paper II, Table 3, Model 1. Separately, general self-efficacy and 
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social support partly mediated the relationship between stress and mental HRQoL. In the 
combined model, stress and general self-efficacy explained a higher variance than the stress-
social support model, indicating that social support does not contribute to greater variance in 
combination with general self-efficacy (Paper II, Table 3). Results demonstrated that general 
self-efficacy mediates the influence of stress on mental HRQoL. However, an independent 
association between stress and mental HRQoL remained.  
A similar model for physical component score is shown in Paper II, Table 4. Stress was slightly 
reduced compared with the main effect model. The association between stress and physical 
component scores remained statistically significant. Hence, there was no evidence for a 
modifying role of social support or general self-efficacy on the stress-physical component score 
relationship. 
Table 4 is included in this thesis to demonstrate the bivariate correlations between the 
background, the independent variables and the outcome variables.  
 
Table 4. Bivariate Pearson's correlations of gender, age, living with partner or not, education, disease duration, PCS and 
MCS, IES, ISEL and GSE. (n = 165). 
 1 2 3 4 5 6 7 8 9 10 
1 Gender 1          
2 Age -.11 1         
3 Living with partner or 
not -.18
* -.16* 1        
4 Education -.25** -.21** .06 1       
5 Disease duration .11 .06 -.03 -.16 1      
6 PCS -.10 -.31** .08 .26** -.18* 1     
7 MCS -.04 -.00 -.04 .01 -.12 .10 1    
8 CRS .02 .09 .02 -.13 .04 -.24** -.53** 1   
9 SS .08 -.26** .11 -.18* -.15 .24** .35** -.31** 1  
10 GSE -.02 -.23** .04 .11 -.12 .24** .47** -.18* .38** 1 
**. Correlation is significant at the 0.01 level  
*. Correlation is significant at the 0.05 level  
Abbreviations: 
PCS: Physical component scores 
MCS: Mental component scores 
CRS: Impact of event scores 
SS: Interpersonal social evaluation list 
GSE: General self-efficacy  
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7.3  Sample characteristics for the exploratory study 
Those who completed the intervention (N = 37) (Flow diagram) ranged in age from 36 to 
80 years and women and men were nearly equally represented (46% and 54% respectively). The 
majority were currently married or cohabitants (76 %). The participants were relatively well 
educated. Seventy-three percent had an education level of high school or more. Thirty-five 
percent were currently working and 56 % were retired. The average income was high (542 000 
NOK). Thirty-six patients (89 %) had a disease duration of more than 6 months.  Food 
intolerance was the most frequent reported symptom (89 %) and flushing and restlessness were 
the least reported symptoms (19 %).  Twenty-two percent had co-morbid conditions such as 
arthritis, breast cancer and myocardial infarction. Of the 41 patients, only 29 subjects completed 
all three measurements (T1 – T3). Except for those patients who died, the reasons why 
individuals did not participate in the intervention were unknown. A comparison of demographic 
and medical characteristics between those who completed the intervention and those who 
withdrew showed no significant differences in age (p = 0.90) and gender (p = 0.51). 
7.3.1 Patient Education to Improve Stress, General Self-efficacy and Health 
Related Quality of Life in Patients with Neuroendocrine Tumors – a Pilot 
Study (Paper III) 
 
The objective of this paper was to explore changes in stress, general self-efficacy and HRQoL in 
patients with NET following a patient education intervention. Data collected from 37 patients at 
T1, T2, and T3 were used to evaluate changes in stress, general self-efficacy and HRQoL at 
baseline (T1), two weeks post-baseline (T2) six months following the intervention (T3). 
Description of changes in stress, general self-efficacy and mental and physical HRQoL at T1, T2 
and T3 are shown in Paper III, Table 3.  
Baseline scores on the SF-36 mental component were 43.3 (SD = 9.3), on SF-36 physical 
component were 42.1 (SD = 10.1), on stress (IES) were 26 (SD = 13.6) and for general self-
efficacy 31.2 (SD = 3.2) (Paper III, Table 3). We estimated the overall change in outcome 
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measures from T1 to T3. The patients reported significantly improved mean scores over time for 
stress (-2,10, p < 0.01), general self-efficacy (+0.71, p < 0.05) and for the physical component 
score (+3.09, p < 0.01) (Paper III, Table 4). The results suggest a significant improvement in 
stress, general self-efficacy as well as physical status following a patient educational 
intervention. There was no linear effect of time for the mental component scores (0.36; p > 0.05) 
(Paper III, Table 4). The change in general self-efficacy differed significantly between patients 
(random slope = 2.5; p < 0.01), but the changes in physical component score did not vary 
between patients (random slope = 4.11; p < 0.05). There were significant differences in stress 
between patients (random slope = 9.5, p < 0.05) but the changes did not vary within patients 
(random slope 36.9, p = < 0.05). Women had significant better physical health (B = 1.65, p = 
0.05) at baseline than men (Paper III, Table 4).  In addition, the presence of co-morbid 
conditions and one or more symptoms at baseline were negatively associated with physical 
component scores (B = -8.75 and SE = 2.5; B = -4.86 and SE =1.6) following a patient education 
intervention.  
7.4  Summary of results 
In summary, our results support previous research on evidence for associations between 
demographic and background variables and subscores of HRQoL.  The results of Paper I showed 
that those with lower age had better physical functioning and less role limitations than those who 
were older. In addition, physical functioning was higher in patients with more than 16 years of 
education than those with less education than 16 years. Moreover, full time and part time 
workers had significantly better HRQoL than those who did not work. Disease duration was not 
associated with with HRQoL. Finally, results provide new knowledge in that patients with NET 
have poorer HRQoL than the general population. 
Overall results included in Paper II, showed that age and gender had little influence on 
mental and physical HRQoL. Patients with co-morbidity and symptoms had poorer physical 
component scores than those no co-morbidity and symptoms. Stress had a major negatively 
influence on mental HRQoL, whereas social support and general self-efficacy influenced mental 
component score positively. Results support the importance of social support and general self-
efficacy as a mediator  between stress and mental HRQoL.  
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Results from the exploratory study reported in Paper III suggest that an educational 
program might be helpful for patients suffering from NET. The results indicate that patients 
experienced less stress, improved levels of general self-efficacy, and improved their physical 
status six months following a patient education program. In addition, those without present co-
morbidities and those with no symptoms reported better physical functioning compared to those 
with more than one comorbid conditions and those with more than one disease related symptom. 
8. Discussion 
8.1 Methodological considerations 
8.1.1 Design 
Random assignment to experimental or control groups was planned for this study. However, it 
became clear that this would not be possible due to the lack of a consistent national 
identification code for the diagnosis of NET. In addition, the scattered geographic distribution of 
the limited number of patients who agreed to participate in the study made it impossible to 
deliver the intervention to a larger sample. Therefore, we combined a cross sectional design 
(Paper I, II) with a prospective, longitudinal, exploratory  design (Paper III).  
The main aim of the cross sectional survey was to describe HRQoL among a nationwide sample 
of patients with NET compared with a general Norwegian population (Paper 1) and to evaluate 
associations between stress, general self-efficacy, social support and HRQoL  (Paper 2).  Cross 
sectional studies are appropriate in describing the status of a phenomenon or describing 
relationships among phenomena at a fixed point of time [80] such as HRQoL in patients with 
NET compared with the general norm population and psychosocial factors related to HRQoL. 
The correspondence in background variables between this study and previous published studies 
in patients with NET [47;56;121] as well as our large sample size in the cross sectional study are 
important.  Also, 196 of 256 eligible patients consented to participate (paper I and II) 
representing 83 % of the national population of patients diagnosed with GI-NET at that time. 
This indicates that our findings have strong external validity.  However, the sample was not 
large enough to determine causal relationships through path analysis.  
The main aim of the exploratory study was to evaluate changes in stress, general self-efficacy 
 
 
48 
 
and HRQoL among patients with NET following a patient education intervention (Paper III). 
However, a single group design and small sample size were weaknesses of the study and may 
cause threats to the study validity because the lack of control group and representativeness. 
Nevertheless, the exploratory design allowed us to study the dynamics of phenomenon over time 
[80]. Attrition was another limitation in the study and is especially great when the length of time 
between points of data collection is long [80]. The present study lasted for 6 months and 26 of 
39 patients responded at T3 (attrition 33 %). Although there is no absolute standard for 
acceptable attrition rates, biases are usually of concern if the rate exceeds 20 % [80]. The small 
sample in this study resulted in low power, thus increasing the risk of type II errors, i.e. failing to 
demonstrate statistically significant results even though there is an association between the 
variables in the population from which the sample is drawn. The characteristics of the patients 
who dropped is important to know [162] (p. 302), and the enrollment flow diagram shows an 
overview of participants and the number of dropouts at each  point in time. We do not know why 
patients dropped out of the study except for those two who died. Three men and four women 
dropped out and the characteristics of the dropouts suggest that they were younger than of the 
sample. Such high withdrawal rate may be a limitation and may decrease the internal and 
external validity of our findings [80].  
Living with a chronic disease may be experienced as a process (illness trajectory) consisting of 
regressive steps, with acute, stable and downward phases [54]. Patients with NET may report 
different HRQoL because they are at different points in their illness trajectory at the time when 
measurements take place. A longitudinal, RTC would strengthen internal validity by controlling 
for the possible confounders of individual characteristics, disease progression, treatments, and 
settings [80].  
8.1.2 Sample size and representativeness 
The sample of the cross sectional, descriptive survey (Paper I, II) consisted of patients with NET 
from a nationwide population. Cross sectional surveys are appropriate for describing the status 
of a phenomena or for describing the relationship among phenomena at a fixed point of time 
[80]. However, a methodological challenge of our survey was to collect data from a 
representative sample. Because of the lack of codes for identification of the diagnosis related 
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group, we were dependent on the physicians in the NET centers and their willingness to identify 
patients in databases based on different search terms. However, the different NET centers had 
their own identification codes for patients with NET and the patients were identified on that 
basis. Given the small sample and low power, we were unable to detect small effects which are 
common in interventional research [71].  Thus, we are cautious in interpreting changes in stress, 
general self-efficacy and HRQoL in patients with NET. A convenience sampling may have 
biased our sample in the exploratory  study (Paper III) towards subject with less stress, higher 
general self-efficacy and HRQoL. As the mean values of stress were of a level of a small to 
medium degree we may indicate that the levels of stress was not so high that it activated the 
avoidance behavior which would make them less likely to approach the patient education 
intervention, but still enough to stimulate the initiative to participate the intervention. In 
addition, the necessitation of a single group design we could not explain the causation of the 
changes because we had no control group.  
8.1.3 The Patient Education Intervention 
The key goal for the patient education intervention was to help NET-patients strengthen their 
own competence/capacity and self-efficacy and to be able to take part in their self-development, 
adaptation and self-renewal over time. There were several strengths of the patient educational 
program in this study. First, the intervention was designed in accordance with approved 
guidelines by Lorig [61]  based on Bandura`s social cognitive agent theory and the construct of 
self-efficacy  [90]. Social cognitive theory is well established and has been used as a basis in 
interventions in patients with chronic diseases for decades, particularly by Lorig and her 
colleagues. Results from intervention studies carried out based on the principles of self-efficacy 
in patients with chronic conditions have shown significantly increased levels of self-efficacy[61] 
. In addition, interventions based on the theory of social cognitive theory and the construct of 
self-efficacy have shown improved quality of life in the general population [163]as well as in 
chronic ill populations [106;123]. Second, researchers claim that  individuals patients were 
motivated by their own goal setting that may lead to healthier behaviors [32;33;61;90;164]. 
Third, eight nurses organized and carried out the patient educational program at the hospital 
units where the patients with NET were referred (paper III). One possible advantage of carrying 
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out a patient educational program by different nurses and not by the project investigator might 
be that the nurses may not bias the results such as the project investigator may do [165]. 
Furthermore, the nurses could counsel each other during the implementation. Finally, the nurses 
were writing logs after every group session and individual telephone call to ensure fidelity to the 
model of the principles of self-efficacy.  The idea of this log was to help the nurses to reflect on 
the use of the four principles of self-efficacy.  
One follow-up per week for 26 weeks was chosen as a reasonable dose and 26 weeks was 
chosen for the length of time for the intervention [68]. Changes in knowledge and self-
development may occur within weeks, but behavioral and lifestyle changes require longer period 
of time [68]. Longer programs generally achieve more favorable outcomes [32;33].  
The intervention groups started either in the spring or in the fall from 2005-2007. The first phase 
of the intervention took place at a residential rehabilitation facility for patients with cancer.  
Patients stayed for four days. Partners were welcome to take part in the lectures and separate 
group talks. The decision to utilize a cancer center which the patients had to travel and stay for 
four days, may have been a limitation. Some patients reported that the location of the first phase 
made it impossible for them to participate in the intervention. A strength of the intervention 
schedule was that patients could chose to participate either in the spring or the fall. In addition, 
the first phase of the intervention might have been burdensome because of the time commitment 
required  and thus may have excluded eligible patients. For all the groups, the same person gave 
the lectures every time. The topics of the lectures were chosen in collaboration with the patients, 
physicians, nutritionist, social worker and nurses. In addition, content was based on evidenced-
based  knowledge of the disease, symptoms and knowledge of how a chronic disease may affect 
one’s daily life.  
8.1.4 Instruments and research data 
The measurements used in this study are well established, have shown acceptable psychometric 
properties, and have been used in studies with cancer patients internationally. Although there 
may be concerns as to whether the questionnaires may potentially harm participants, some of the 
patients told the special nurses after finishing the intervention and questionnaires, that their self-
understanding had increased as a result of the intervention and that the intervention had been of 
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help in formulation their own thoughts and feelings throughout the intervention.   
8.1.4.1 Health Related Quality of Life 
There are several advantages in using a well-established generic questionnaire to measure 
HRQoL.  The SF-36 is widely used which made it possible to compare our results with previous 
research. It is also possible to determine the burden of disease in different groups of patients 
when comparing our research with previous research. We wanted to evaluate the health related 
quality of life as whole and not only factors related to the disease, thus, we chose to use the 
generic SF-36.  
Norm based comparison was performed with an age and gender matched Norwegian sample that 
had used the same measurement for assessing HRQoL (Paper I)[153]. Norm based comparison 
may contribute to a better understanding of the research and clinical significance of our results.  
8.1.4.2 Impact of Event Scale 
We used Impact of Event Scale (IES) to measure stress  (Paper II, III). Marit Gilje Jaatun 
translated the questionnaire (personal email contact with Anniken Hamang Carlsson, 2009).  
This version was used in earlier Norwegian studies on psychosocial aspects of medical genetics 
[8] and operable breast cancer [166]. Thus, we considered it an advantage to use this version for 
comparisons. When comparing results with other studies, it is important to keep in mind that 
there exist another version of IES with different responses [88].  
8.1.4.3 Interpersonal Evaluation List 
The Interpersonal Evaluation List (ISEL) was chosen to measure social support. Although the 
version has five subscales; appraisal support, self-esteem support, group belonging, emotional 
closeness, tangible aid, we decided to use ISEL as a single variable because we were limited in 
how many predictor variables we could enter into a regression model. Appraisal support, group 
belonging and tangible aid demonstrated satisfactory reliability whereas self-esteem support and 
emotional closeness scale showed lower satisfactory reliability in this sample. 
8.1.4.4 General Self-efficacy 
The General self-efficacy questionnaire is constructed based on Bandura’s theory. However, the 
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general version reflects various domains of functioning in which people judge how efficacious 
they are. The total summary of the general self-efficacy scale demonstrated satisfactory 
reliability in Paper II and III. 
8.2 General discussion of the findings 
The aim of this thesis is to expand the basis of knowledge on HRQoL with regard to patients 
with NET. In the first paper we described HRQoL in a nationwide sample of patients with NET 
compared with a general Norwegian population (Paper I). In the second paper, we evaluated 
how stress, general self-efficacy and social support were related to HRQoL and whether or not 
general self-efficacy and social support mediate the association between stress and HRQoL 
(Paper II). In the third paper , we evaluated the changes in stress, general self-efficacy and 
HRQoL following a patient education intervention based on the principles of self-efficacy 
(Paper III). The results demonstrated that patients with NET had poorer HRQoL than the general 
Norwegian population (Paper I), that being diagnodes with NET had a negative influence on  
HRQoL, and  that social support and general self-efficacy played a mediation role in the 
relationship between stress and HRQoL (Paper II).  Finally, we found that general self-efficacy, 
stress and physical HRQoL improved significantly following an intervention based on the 
principles of self- efficacy (Paper III).    
8.2.1   Health related quality of life in patients with NET compared with the general 
Norwegian population 
Findings shown in Paper I demonstrated different patterns with regard to the relationship 
between background and disease related characteristics and HRQoL in patients with NET (Paper 
I, Table 3), and they reported worse HRQoL outcomes compared to the general Norwegian 
population on all subscales of the SF-36 (Paper I, Table 4). Contrary to findings in Larsson’s 
study [167], we found that the background characteristics associating with HRQoL were 
primarily due to age, gender, education and employment working situation. Variations in the 
influence of age across studies may be explained by differences in categorizing age [108]. 
Similar to our findings,  Larsson et al [167] found no relationship between length of time since 
diagnosis and HRQoL measured by EORTC QLQ-C30. However, in another study, HRQoL was 
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shown to be better 5 years after diagnosis than it was closer to the time of diagnosis [168]. 
However, no conclusions can be drawn about the degree to which these categories are 
problematic or important.  
After adjusting for background characteristics, our results are consistent with those found in 
Swedish [48] and two samples compared with American general populations [13;169]. In 
addition, patients with pancreatic neuroendocrine tumor (n = 44) demonstrated significantly 
lower MCS than the Italian general population, similar to our results. However, our results were 
inconsistent with findings of patients with multiple endocrine neoplasia1 (MEN1) relative to the 
Swedish population, except from the levels of general health and social functioning [47]. Results 
indicate that patients with NET represent a group with advanced cancer and that the majority of 
the patients with NET have metastatic disease (70 %) [53;170;171]. The largest differences in 
HRQoL between patients with NET responding in this study, and the general Norwegian 
population were general health perceptions, role physical limitation and vitality. Finally, the 
patients’ ability to participate in activities in daily life was limited.  
The present study has expanded our knowledge about the relationship between background 
characteristics and the SF-36 subscales in patients with NET. In addition, this study has 
confirmed the impact of quality of life when diagnosed with NET compared to the Norwegian 
general population.  
8.2.2 Associations between stress, general self-efficacy and social support related 
to HRQoL 
Findings reported in Paper II are consistent with  findings of patients treated for breast cancer 
[11] and long-term survivors of testicular cancer [10], and  demonstrated that patients with NET 
reported higher levels of stress and  decreased physical and mental HRQoL. Reduced mean 
levels of mental HRQoL indicate important signs of stress.  
Our results  demonstrated that more social support was associated with better mental health 
(Paper 2, Table III). This has been demonstrated in earlier research [8]. More information, 
advice and feed-back as well as self-confidence and tangible aid are important factors resulting 
in better mental HRQoL in patients with NET. Developing a serious disease such as NET may 
imply difficulties in continuing activities of daily living, thus the need for social support seems 
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logical. Concerns about receiving adequate information, advice and tangible aid might add to 
stress in patients with NET. Thus, information and practical support might increase the level of 
mental health. 
Our findings demonstrated that general self-efficacy was positively related to mental and 
physical HRQoL (Paper II, Table 3). This is congruent with previous results demonstrating a 
positive relationship between general self-efficacy and physical HRQoL in patients with HIV 
[172] and mental HRQoL  in individuals at risk for hereditary cancer [8]. However, the results 
contrast with a study of individuals at risk for hereditary cancer for  physical HRQoL [8]. One 
explanation for the findings may be that those who experience more confidence in managing 
disease may have better capability to handle complex tasks [33;173]. Another explanation may 
be that those with higher level of general self-efficacy experience are more capable and more 
confidence to perform physical activities. A third explanation may be that we used a generic 
questionnaire measuring the patients’ self-efficacy. A generic measurement is likely to capture 
more characteristics of self-efficacy. A   disease specific measure may be superior to a generic 
instruments by tapping aspects of self-efficacy that are of particular relevance to people with the 
condition of interest [71] (p 5). Thus, including a disease specific self-efficacy questionnaire 
could be a supplement to a generic questionnaire in order to be more sensitive to symptoms that 
might cause the stress response related to the disease. Nevertheless, results from this study 
indicate that positive feelings, thoughts, and expectations are important components for both 
mental and physical HRQoL in patients with NET.  
Finally, social support and general self-efficacy partially mediated the relationship between 
stress and mental HRQoL (Paper II, Table 3, Model 3). However, general self-efficacy 
accounted for the largest amount of variance in the combined model of stress and mental 
HRQoL. Although general self-efficacy played a main role in the mediator model, more research 
is needed to explore the importance of disease related self-efficacy and the stress-HRQoL 
relationship. It might be that a combination of social support and disease related self-efficacy 
play a more important role in the stress-HRQoL relationship. Nevertheless, general self-efficacy 
decreases the influence of stress on mental HRQoL in patients with NET. No prior studies have 
reported this relationship, indicating that the present study has expanded the knowledge of social 
support, self-efficacy, stress, and HRQoL. However, further research is needed to confirm our 
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findings.   
8.2.3 Patient education to improve stress, general self-efficacy and HRQoL in 
patients with neuroendocrine tumors – a pilot study 
Results reported in Paper III demonstrated that stress was reduced and general self-efficacy and 
physical functioning were improved following the patient education intervention. This is 
consistent with social cognitive theory and the understanding of how self-efficacy may influence 
how people think, feel and act [90]. Consequently, the findings suggest that the patients’ gained 
knowledge and problem-solving abilities on which skills are grounded, and thus can make 
appropriate choices for how to overcome barriers associated with NET.  Looking at cancer as a 
reasonable comparison group for our results systematic reviews report on several intervention 
studies in which new skills were acquired and patients gained confidence to manage their 
disease [34-36;127]. However, the effects of these interventions show various effects with 
regard to outcomes such as stress, self-efficacy, and HRQoL. Although the interventions in the 
studies seem to be of substantially similarities, the concepts of the outcomes being measured are 
different.  
A literature review of RTC by McGregor & Antony show reduced levels of stress following 
cognitive behavioral interventions in women treated for breast cancer [174]. In a  RTC using 
cognitive-behavioral therapy in the intervention for women with breast cancer (n = 425) stress 
(measured by the intrusion subscale of The Impact of Event scale) was reduced following the 
intervention [143]. Chan et al. conducted a RTC including a psycho-educational intervention in 
women with gynecologic malignancy. The intervention aimed to help patients see the integral 
link between thoughts, emotions and physical well being. The findings revealed no 
improvements in stress by The Impact of Event Scale [175].  
 In our pilot study fifty-seven percent of the patients had moderate levels of stress, and 2.7 % of 
the sample reported severe stress. Changes in stress following the intervention may reflect that 
patients did not have stress so high that they activated avoidance behavior and were able to 
participate in the intervention. Consequently, the significant changes in the levels of stress may 
be of limited relevance.  
Statistically significant changes tell us about effect sizes but do not necessarily reflect clinical 
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importance.  A standardized estimation of effect size could be applied in the interpretation of the 
results [159]. The effect size for the changes in stress from T1 to T3 was 0.16 and may be 
considered as small. Thus, though the sample was small we were able to detect change.  The 
clinical relevance of the improvements in stress is probably significant but would require long 
term follow-up to determine.  
General self-efficacy was evaluated adjusting for   age, gender, symptoms, and co-morbidity and 
demonstrated significant improvements. The results indicated that the patients have had the 
capacity to improve their confidence in managing their general, everyday challenges (Paper III, 
Table 4). Tamagawa et al summarized benefits from psychosocial interventions in oncology and 
indicated that those with low levels of self-efficacy initially benefitted from psychosocial 
interventions however, those with higher levels of self-efficacy at baseline did not. [127].   
Similar to our findings in self-efficacy improved following a nurse led RTC for patients with 
congestive heart failure following a self-management program [176]. Our findings were also 
similar to patients with long-term conditions improving disease specific self-efficacy following 
peer led education program based on the principles of self-efficacy [41;105;107]. However, 
Ritter, Lee and Lorig [177] emphasize that those with lower initial self-efficacy benefit more 
from a patient education intervention than those with higher levels.  In addition, Tamagawa et al 
[127] claim that benefits of psychosocial interventions are more salient for patients who reported 
lower psychological and physical HRQoL and fewer social resources  at baseline. We did not 
adjust for baseline levels of general self-efficacy, physical HRQoL, and social support in this 
study.  
The estimated effect size for change in general self-efficacy was 0.32, which may be interpreted 
as a small to moderate change. This may indicate clinical significance but would require follow-
up measures of patient characteristics and outcomes.  
Similar to our findings, HRQoL has also been improved through educational interventions in 
other cancer populations [38;150] showing significantly improvements in physical HRQoL 
following patient education. Testing of RTC’s in two interventions, one based on education-only 
and education-plus-group discussion, men (n = 279) with prostate cancer demonstrated 
significant improvements in PCS in the education-plus discussion group [178]. Doorenbos et al. 
showed that physical function measured by the SF-36 improves significantly in individuals with 
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solid tumor cancer (n = 237) following an intervention based on cognitive behavioral theory 
[179]. However, findings from a study in women with gynecologic malignancy aiming to 
evaluate the effectiveness of psycho-educative and cognitive intervention showed no 
improvements in cancer specific HRQoL following the intervention [175].  
Men had a significantly larger change in PCS compared to women in this study. The lower 
baseline scores of PCS among men may explain the differences in change, as men had a greater 
potential for improving their PCS than women.  Consistent with earlier research [179] co-morbid 
conditions were related to reduced physical function. Research has shown that interventions 
based on principles of self-efficacy have positive effects on those with greater risk of lower 
physical functioning [179].  
The effect size for total change of physical components scores from T1 to T3   was 0.37. This 
moderate effect may indicate that the change may be meaningful [159]. The patient education 
intervention was mainly designed to help patients to believe in their own competence by 
changing thinking patterns. Moreover, the intervention is complex in that, the intervention 
consists of a number of components such as those who receiving and delivering the intervention, 
different groups targeted by the intervention and the setting of the intervention. These 
components may interact and influence the study outcomes [180]. Consequently, which 
component that is most potent may be uncertain.  
Moreover, functional status and symptoms not measured in this study such as fatigue, disturbed 
sleeping pattern may influence physical HRQoL in patients with NET’. In addition, as 
aggressiveness of the disease and side effects of NET medication could influence the patients’ 
physical activity. Measuring aggressiveness and side effects would increase the significance of 
changes in physical HRQoL following an intervention based on the principles of self-efficacy. 
Hence, future longitudinal RTCs should include biological function and functional status and, 
side effect of NET mediacation and treatment  in HRQoL studies.   
9. Conclusion 
The aims of this thesis were to describe HRQoL in a nationwide sample of patients with NET 
compared with a general Norwegian population (Paper I), evaluate associations between stress, 
general self-efficacy, social support and HRQoL  (Paper II) and, to test the mediation role of 
 
 
58 
 
social support and general self-efficacy on the stress – HRQoL association (Paper II) and, to 
explore changes in stress, general self-efficacy and HRQoL among patients with NET following 
a patient education intervention (Paper III). The present study provides novel knowledge of 
these variables that can be used by clinicians for treatment and care of patients with NET.  Main 
findings include: 
x Patients with NET had poorer HRQoL than the general Norwegian population on all 
subscales of the SF-36. 
x Lower age, part-time or full-time employment, higher education and  higher income 
levels were associated  better HRQoL. Having symptoms and co-morbid conditions 
predicted poorer HRQoL 
x Higher stress was associated with poorer mental and physical HRQoL  
x Higher levels of social support and general self-efficacy were associated with better 
mental HRQoL  
x Higher levels of general self-efficacy were associated with better physical HRQoL. 
x Social support and general self-efficacy mediated the relationship between stress-and 
mental HRQoL.  
x Stress, general self-efficacy and physical HRQoL changed significantly following a 6- 
month patient educational intervention. 
x Symptoms and co-morbidity were inversely associated with physical HRQoL. 
9.1 Implications 
9.1.1 Implications for clinical practice 
Poorer HRQoL among patients with NET compared with the general Norwegian population 
indicate that health care personnel who have frequent contact with patients should intervene as 
specific mental and physical issues arise.  Talking with the patients about their challenges and 
assisting with goal setting could accomplish this. According to Norwegian legislation requires 
that [60]  patients receive  routine information and education that improves  their coping, 
maintains health,  independence, and functional ability. Health care personnel should refer 
patients to other social service agencies or clinicians who can provide social and psychological 
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support when needed. One major challenge in clinical practice is to identify individual needs. 
Screening the patients with NET for stress during follow up may give useful information 
augment care. In the present study, 12 % of the patients reported a severe stress response to 
cancer indicating a need for assistance with coping. Results also confirm the importance of 
screening all patients with NET for stress levels since stress was negatively associated  with 
mental and physical HRQoL.  IES (Impact of Event Scale, see p 41) might work as a screening 
tool as it is brief and could be incorporated into nursing assessments.   
  Encouraging patients with NET to engage in social activities would aid in their coping 
and increase self-efficacy. Supporting the patients competence in performing specific behaviors 
and   may help them manage symptoms and improve their HRQoL. Because NET is incurable, 
facilitating and concentrating on increasing general self-efficacy and motivating the individuals’ 
self-care might be useful.  Screening for stress, social support, and general self-efficacy at 
diagnosis should be considered. Information from the screening could be used in discharge 
planning and in rehabilitation programs.   
9.1.2 Implication for future research 
Because patients with NET report decreased HRQoL compared with a gender and age matched 
Norwegians, further research on other clinical variables that are predictive of favorable 
outcomes is warranted.  
We found no association between length of time since diagnosis and HRQoL (Paper I) however, 
cancer specific HRQoL has shown to improve five years after diagnosis in another study [168]. 
Conflicting results indicate more research on the impact of disease duration on HRQoL would 
be beneficial.  Future research might examine the influence of symptoms such as pain, fatigue 
and diarrhea. These symptoms may result in decreased physical activity and thus, reduced 
HRQoL.  
Stress was associated with poorer mental HRQoL in NET patients and general self-efficacy 
seems to be an important predictor of favorable mental HRQoL outcome among patients with 
NET. Thus, a RTC adjusted for the possible confounders of individual characteristics as well as 
disease progression, medical treatments, settings, co-morbid conditions and symptoms would be 
sufficient. Tailored interventions based on age and gender are warranted and more research is 
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needed to evaluate this. Path analyses would be helpful to determine moderator and mediator 
variables and facilitate refinement of interventions. In addition, disease specific self-efficacy 
questionnaire could be a supplement to a generic questionnaire in order to be more sensitive to 
symptoms that might cause the stress response. In addition, stress specifically related to NET 
and NET-related HRQoL may add knowledge about specific problems in order to achieve 
reduced levels of stress related to NET. Finally, the role of social support, which is claimed to be 
an resource for self-efficacy in the social cognitive theory [90], could be a means to address in a 
RTC. 
Optimal outcomes require supporting principles of patient centered- care and promotion of the 
principles of self-efficacy. Qualitative methods such as in-depth interviews, focus groups and 
participant observation may aid in the development of tailored interventions.  
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